Pathway,Celltype,Cor,Enrich_Score,Padj
ADIPOGENESIS,B cells Memory,-0.554502618752945,0,> 0.05
ADIPOGENESIS,B cells Naive,-0.230373663480225,NA,> 0.05
ADIPOGENESIS,CAFs MSC iCAF-like,-0.451776292541956,0,> 0.05
ADIPOGENESIS,CAFs myCAF-like,-0.713786131989159,0,> 0.05
ADIPOGENESIS,Cancer Basal SC,-0.397381267110078,-1.62721550960004,0.00373853935181429
ADIPOGENESIS,Cancer Cycling,-0.0678200890962444,0,> 0.05
ADIPOGENESIS,Cancer Her2 SC,0.0590063290880365,0,> 0.05
ADIPOGENESIS,Cancer LumA SC,0.244168401134751,0,> 0.05
ADIPOGENESIS,Cancer LumB SC,0.0308400214411964,0,> 0.05
ADIPOGENESIS,Cycling PVL,-0.241966930165397,0,> 0.05
ADIPOGENESIS,Cycling T-cells,-0.484704616450654,0,0
ADIPOGENESIS,Cycling Myeloid,0.117021301074147,0,> 0.05
ADIPOGENESIS,DCs,-0.368493024144115,0,> 0.05
ADIPOGENESIS,Endothelial ACKR1,-0.799193974341097,-1.88263645005821,7.77204951255267e-07
ADIPOGENESIS,Endothelial CXCL12,-0.575818986553516,0,> 0.05
ADIPOGENESIS,Endothelial Lymphatic LYVE1,-0.546416018512736,0,0
ADIPOGENESIS,Endothelial RGS5,-0.712332976731279,-1.58545017167768,0.00269543993079412
ADIPOGENESIS,Luminal Progenitors,-0.463882128067977,NA,> 0.05
ADIPOGENESIS,Macrophage,-0.347000683025391,-1.8426843556121,1.7851276004393e-05
ADIPOGENESIS,Mature Luminal,-0.38348913807129,NA,> 0.05
ADIPOGENESIS,Monocyte,-0.350689057048099,0,> 0.05
ADIPOGENESIS,Myoepithelial,-0.0387643239318608,NA,> 0.05
ADIPOGENESIS,NK cells,-0.469172270942162,-1.65192258022593,0.0036258156801681
ADIPOGENESIS,NKT cells,-0.494469860143919,0,> 0.05
ADIPOGENESIS,Plasmablasts,-0.41993452746179,-1.78337959009916,0.000197872975668111
ADIPOGENESIS,PVL Differentiated,-0.694388224046888,0,> 0.05
ADIPOGENESIS,PVL Immature,-0.803233240821041,-1.81681224468289,6.94812069441175e-05
ADIPOGENESIS,T cells CD4+,-0.437685420071474,-1.80872982485004,4.46103445023941e-05
ADIPOGENESIS,T cells CD8+,-0.467314934473663,-1.74844812667676,2.61958191252892e-05
ALLOGRAFT REJECTION,B cells Memory,0.284656188851198,0,> 0.05
ALLOGRAFT REJECTION,B cells Naive,0.210268094621607,NA,> 0.05
ALLOGRAFT REJECTION,CAFs MSC iCAF-like,0.10546955141302,0,> 0.05
ALLOGRAFT REJECTION,CAFs myCAF-like,-0.183933190580521,0,> 0.05
ALLOGRAFT REJECTION,Cancer Basal SC,-0.214835948570631,0,> 0.05
ALLOGRAFT REJECTION,Cancer Cycling,-0.487935086213724,0,> 0.05
ALLOGRAFT REJECTION,Cancer Her2 SC,-0.506259460582959,0,> 0.05
ALLOGRAFT REJECTION,Cancer LumA SC,-0.481520057386433,0,> 0.05
ALLOGRAFT REJECTION,Cancer LumB SC,-0.491455053570024,-1.51043379956297,0.0321069496509786
ALLOGRAFT REJECTION,Cycling PVL,-0.160814003604421,0,> 0.05
ALLOGRAFT REJECTION,Cycling T-cells,-0.0652680767285541,0,0
ALLOGRAFT REJECTION,Cycling Myeloid,0.0838841804215423,0,> 0.05
ALLOGRAFT REJECTION,DCs,-0.400009923373192,0,> 0.05
ALLOGRAFT REJECTION,Endothelial ACKR1,-0.436844988512697,0,> 0.05
ALLOGRAFT REJECTION,Endothelial CXCL12,-0.624621946973462,0,> 0.05
ALLOGRAFT REJECTION,Endothelial Lymphatic LYVE1,-0.202126381762883,0,0
ALLOGRAFT REJECTION,Endothelial RGS5,-0.436813351934074,0,> 0.05
ALLOGRAFT REJECTION,Luminal Progenitors,-0.373791334732116,NA,> 0.05
ALLOGRAFT REJECTION,Macrophage,-0.130566870796002,0,> 0.05
ALLOGRAFT REJECTION,Mature Luminal,0.25085747455648,NA,> 0.05
ALLOGRAFT REJECTION,Monocyte,-0.181689704077238,0,> 0.05
ALLOGRAFT REJECTION,Myoepithelial,-0.00675247970763112,NA,> 0.05
ALLOGRAFT REJECTION,NK cells,-0.35394714355644,0,> 0.05
ALLOGRAFT REJECTION,NKT cells,-0.469355368918694,0,> 0.05
ALLOGRAFT REJECTION,Plasmablasts,-0.496453133642836,0,> 0.05
ALLOGRAFT REJECTION,PVL Differentiated,0.0730890015806449,0,> 0.05
ALLOGRAFT REJECTION,PVL Immature,-0.272246355452704,0,> 0.05
ALLOGRAFT REJECTION,T cells CD4+,-0.188496713836898,0,> 0.05
ALLOGRAFT REJECTION,T cells CD8+,-0.392766625518154,0,> 0.05
ANDROGEN RESPONSE,B cells Memory,0.492201691403976,0,> 0.05
ANDROGEN RESPONSE,B cells Naive,-0.0685412512890637,NA,> 0.05
ANDROGEN RESPONSE,CAFs MSC iCAF-like,-0.554291495234155,0,> 0.05
ANDROGEN RESPONSE,CAFs myCAF-like,0.194701479080762,0,> 0.05
ANDROGEN RESPONSE,Cancer Basal SC,0.0560029003971815,0,> 0.05
ANDROGEN RESPONSE,Cancer Cycling,0.250471119599372,0,> 0.05
ANDROGEN RESPONSE,Cancer Her2 SC,0.176840122419718,0,> 0.05
ANDROGEN RESPONSE,Cancer LumA SC,0.473906739035072,0,> 0.05
ANDROGEN RESPONSE,Cancer LumB SC,0.285293464602172,0,> 0.05
ANDROGEN RESPONSE,Cycling PVL,-0.206035385460837,0,> 0.05
ANDROGEN RESPONSE,Cycling T-cells,-0.191905946378358,0,0
ANDROGEN RESPONSE,Cycling Myeloid,0.314522644226875,0,> 0.05
ANDROGEN RESPONSE,DCs,0.479633919649789,0,> 0.05
ANDROGEN RESPONSE,Endothelial ACKR1,-0.0908983073564637,0,> 0.05
ANDROGEN RESPONSE,Endothelial CXCL12,0.0747703460294949,0,> 0.05
ANDROGEN RESPONSE,Endothelial Lymphatic LYVE1,0.016817599260702,0,0
ANDROGEN RESPONSE,Endothelial RGS5,-0.411812432258375,0,> 0.05
ANDROGEN RESPONSE,Luminal Progenitors,-0.188943033558759,NA,> 0.05
ANDROGEN RESPONSE,Macrophage,0.0393665631638931,0,> 0.05
ANDROGEN RESPONSE,Mature Luminal,-0.21483912167363,NA,> 0.05
ANDROGEN RESPONSE,Monocyte,0.163682935029344,0,> 0.05
ANDROGEN RESPONSE,Myoepithelial,-0.0156458116272768,NA,> 0.05
ANDROGEN RESPONSE,NK cells,-0.487454530428958,0,> 0.05
ANDROGEN RESPONSE,NKT cells,-0.199952634178221,0,> 0.05
ANDROGEN RESPONSE,Plasmablasts,-0.610882760279876,0,> 0.05
ANDROGEN RESPONSE,PVL Differentiated,-0.0658876182479324,0,> 0.05
ANDROGEN RESPONSE,PVL Immature,-0.235831110479443,0,> 0.05
ANDROGEN RESPONSE,T cells CD4+,-0.385823150165759,0,> 0.05
ANDROGEN RESPONSE,T cells CD8+,-0.0914379898103415,0,> 0.05
ANGIOGENESIS,B cells Memory,-0.321854319283411,0,> 0.05
ANGIOGENESIS,B cells Naive,-0.1795968476724,NA,> 0.05
ANGIOGENESIS,CAFs MSC iCAF-like,0.232377019941917,0,> 0.05
ANGIOGENESIS,CAFs myCAF-like,0.448533043467786,0,> 0.05
ANGIOGENESIS,Cancer Basal SC,0.00320926805218425,0,> 0.05
ANGIOGENESIS,Cancer Cycling,-0.164412343602273,0,> 0.05
ANGIOGENESIS,Cancer Her2 SC,-0.134824184801265,0,> 0.05
ANGIOGENESIS,Cancer LumA SC,-0.400882390044872,0,> 0.05
ANGIOGENESIS,Cancer LumB SC,-0.108102426029775,0,> 0.05
ANGIOGENESIS,Cycling PVL,0.388939441581035,0,> 0.05
ANGIOGENESIS,Cycling T-cells,-0.0861151590117804,0,0
ANGIOGENESIS,Cycling Myeloid,0.548412360533568,0,> 0.05
ANGIOGENESIS,DCs,0.0580959430215123,0,> 0.05
ANGIOGENESIS,Endothelial ACKR1,0.141866821684107,0,> 0.05
ANGIOGENESIS,Endothelial CXCL12,0.394152393238085,0,> 0.05
ANGIOGENESIS,Endothelial Lymphatic LYVE1,0.0109853766844632,0,0
ANGIOGENESIS,Endothelial RGS5,-0.178239055212763,0,> 0.05
ANGIOGENESIS,Luminal Progenitors,0.247210478644276,NA,> 0.05
ANGIOGENESIS,Macrophage,0.705842490037162,0,> 0.05
ANGIOGENESIS,Mature Luminal,0.301494551680658,NA,> 0.05
ANGIOGENESIS,Monocyte,0.246006663493402,0,> 0.05
ANGIOGENESIS,Myoepithelial,-0.212042649998346,NA,> 0.05
ANGIOGENESIS,NK cells,0.0645705195403164,0,> 0.05
ANGIOGENESIS,NKT cells,-0.0398679996102229,0,> 0.05
ANGIOGENESIS,Plasmablasts,0.249133830074535,0,> 0.05
ANGIOGENESIS,PVL Differentiated,0.307445234601863,0,> 0.05
ANGIOGENESIS,PVL Immature,0.241974083702978,0,> 0.05
ANGIOGENESIS,T cells CD4+,0.152680406820689,0,> 0.05
ANGIOGENESIS,T cells CD8+,0.186663110221203,0,> 0.05
APICAL JUNCTION,B cells Memory,-0.00255344929189631,0,> 0.05
APICAL JUNCTION,B cells Naive,-0.2207179045907,NA,> 0.05
APICAL JUNCTION,CAFs MSC iCAF-like,0.230129067305169,0,> 0.05
APICAL JUNCTION,CAFs myCAF-like,0.564509036798376,0,> 0.05
APICAL JUNCTION,Cancer Basal SC,0.549679407697349,0,> 0.05
APICAL JUNCTION,Cancer Cycling,0.525030434257566,0,> 0.05
APICAL JUNCTION,Cancer Her2 SC,-0.0364480032160602,0,> 0.05
APICAL JUNCTION,Cancer LumA SC,0.297141948537378,0,> 0.05
APICAL JUNCTION,Cancer LumB SC,0.356229776231128,0,> 0.05
APICAL JUNCTION,Cycling PVL,0.315309510790284,0,> 0.05
APICAL JUNCTION,Cycling T-cells,-0.186199504258176,0,0
APICAL JUNCTION,Cycling Myeloid,-0.102489929580302,0,> 0.05
APICAL JUNCTION,DCs,0.0201613384504191,0,> 0.05
APICAL JUNCTION,Endothelial ACKR1,-0.0501694740094013,0,> 0.05
APICAL JUNCTION,Endothelial CXCL12,0.303384859708089,0,> 0.05
APICAL JUNCTION,Endothelial Lymphatic LYVE1,0.481534103190197,0,0
APICAL JUNCTION,Endothelial RGS5,0.137753305162676,0,> 0.05
APICAL JUNCTION,Luminal Progenitors,0.04343965873002,NA,> 0.05
APICAL JUNCTION,Macrophage,-0.0986355359486717,0,> 0.05
APICAL JUNCTION,Mature Luminal,0.426972031378737,NA,> 0.05
APICAL JUNCTION,Monocyte,-0.147975880349581,0,> 0.05
APICAL JUNCTION,Myoepithelial,0.0250139538264718,NA,> 0.05
APICAL JUNCTION,NK cells,-0.16292934329594,0,> 0.05
APICAL JUNCTION,NKT cells,-0.0870011438349989,0,> 0.05
APICAL JUNCTION,Plasmablasts,0.154277810220659,0,> 0.05
APICAL JUNCTION,PVL Differentiated,0.157804389341127,0,> 0.05
APICAL JUNCTION,PVL Immature,0.100711672334181,0,> 0.05
APICAL JUNCTION,T cells CD4+,-0.0456444886642348,0,> 0.05
APICAL JUNCTION,T cells CD8+,-0.123590884798506,0,> 0.05
APICAL SURFACE,B cells Memory,0.0399042625440521,0,> 0.05
APICAL SURFACE,B cells Naive,-0.00488429186387523,NA,> 0.05
APICAL SURFACE,CAFs MSC iCAF-like,0.482194861396245,0,> 0.05
APICAL SURFACE,CAFs myCAF-like,0.535380876418372,0,> 0.05
APICAL SURFACE,Cancer Basal SC,0.406404183917203,0,> 0.05
APICAL SURFACE,Cancer Cycling,0.692945467620969,0,> 0.05
APICAL SURFACE,Cancer Her2 SC,-0.0561742211504982,0,> 0.05
APICAL SURFACE,Cancer LumA SC,0.802449317682224,0,> 0.05
APICAL SURFACE,Cancer LumB SC,0.630880527361942,0,> 0.05
APICAL SURFACE,Cycling PVL,0.543345151229895,0,> 0.05
APICAL SURFACE,Cycling T-cells,0.0319886127126594,0,0
APICAL SURFACE,Cycling Myeloid,-0.112780500108517,0,> 0.05
APICAL SURFACE,DCs,0.640873302726979,0,> 0.05
APICAL SURFACE,Endothelial ACKR1,0.471237402736984,0,> 0.05
APICAL SURFACE,Endothelial CXCL12,0.449009690548762,0,> 0.05
APICAL SURFACE,Endothelial Lymphatic LYVE1,0.0998845943207016,0,0
APICAL SURFACE,Endothelial RGS5,0.812296881393097,0,> 0.05
APICAL SURFACE,Luminal Progenitors,0.468788357954041,NA,> 0.05
APICAL SURFACE,Macrophage,0.582207234941068,0,> 0.05
APICAL SURFACE,Mature Luminal,0.532880410106733,NA,> 0.05
APICAL SURFACE,Monocyte,0.333344389441938,0,> 0.05
APICAL SURFACE,Myoepithelial,0.158436357993569,NA,> 0.05
APICAL SURFACE,NK cells,0.197836897729514,0,> 0.05
APICAL SURFACE,NKT cells,-0.123122720982483,0,> 0.05
APICAL SURFACE,Plasmablasts,0.565338517231917,0,> 0.05
APICAL SURFACE,PVL Differentiated,0.511124836361061,0,> 0.05
APICAL SURFACE,PVL Immature,0.344298883202098,0,> 0.05
APICAL SURFACE,T cells CD4+,0.175380117309187,0,> 0.05
APICAL SURFACE,T cells CD8+,0.00508456348112998,0,> 0.05
APOPTOSIS,B cells Memory,0.592965325181747,0,> 0.05
APOPTOSIS,B cells Naive,0.392854356131582,NA,> 0.05
APOPTOSIS,CAFs MSC iCAF-like,-0.0692300039263214,0,> 0.05
APOPTOSIS,CAFs myCAF-like,0.347076349315849,0,> 0.05
APOPTOSIS,Cancer Basal SC,-0.158380679872648,0,> 0.05
APOPTOSIS,Cancer Cycling,0.326464709320033,0,> 0.05
APOPTOSIS,Cancer Her2 SC,-0.0265223866449899,0,> 0.05
APOPTOSIS,Cancer LumA SC,0.437547888893601,0,> 0.05
APOPTOSIS,Cancer LumB SC,0.294760683842856,0,> 0.05
APOPTOSIS,Cycling PVL,0.368284379031017,0,> 0.05
APOPTOSIS,Cycling T-cells,0.106028751043439,0,0
APOPTOSIS,Cycling Myeloid,0.452753022212668,0,> 0.05
APOPTOSIS,DCs,0.694869102112143,0,> 0.05
APOPTOSIS,Endothelial ACKR1,-0.262771849178467,0,> 0.05
APOPTOSIS,Endothelial CXCL12,-0.321839978064845,0,> 0.05
APOPTOSIS,Endothelial Lymphatic LYVE1,-0.0379969752909322,0,0
APOPTOSIS,Endothelial RGS5,-0.195084197253614,0,> 0.05
APOPTOSIS,Luminal Progenitors,-0.161675214521521,NA,> 0.05
APOPTOSIS,Macrophage,0.532349007357831,0,> 0.05
APOPTOSIS,Mature Luminal,-0.209447527408711,NA,> 0.05
APOPTOSIS,Monocyte,0.247204614573527,0,> 0.05
APOPTOSIS,Myoepithelial,-0.079202032382694,NA,> 0.05
APOPTOSIS,NK cells,0.0664693401079026,0,> 0.05
APOPTOSIS,NKT cells,0.196651343130734,0,> 0.05
APOPTOSIS,Plasmablasts,-0.259570181505981,0,> 0.05
APOPTOSIS,PVL Differentiated,-0.10579525719962,0,> 0.05
APOPTOSIS,PVL Immature,-0.432719145037653,0,> 0.05
APOPTOSIS,T cells CD4+,0.253018032462766,0,> 0.05
APOPTOSIS,T cells CD8+,0.167355565193334,0,> 0.05
BILE ACID METABOLISM,B cells Memory,-0.323008511726366,0,> 0.05
BILE ACID METABOLISM,B cells Naive,0.174810219605483,NA,> 0.05
BILE ACID METABOLISM,CAFs MSC iCAF-like,-0.0489805404467879,0,> 0.05
BILE ACID METABOLISM,CAFs myCAF-like,-0.412944609794495,0,> 0.05
BILE ACID METABOLISM,Cancer Basal SC,-0.105049175325734,0,> 0.05
BILE ACID METABOLISM,Cancer Cycling,0.16458604770126,0,> 0.05
BILE ACID METABOLISM,Cancer Her2 SC,0.547437430379594,0,> 0.05
BILE ACID METABOLISM,Cancer LumA SC,0.184626185467569,0,> 0.05
BILE ACID METABOLISM,Cancer LumB SC,0.216551918359317,0,> 0.05
BILE ACID METABOLISM,Cycling PVL,-0.563488106259655,0,> 0.05
BILE ACID METABOLISM,Cycling T-cells,-0.126848549284217,0,0
BILE ACID METABOLISM,Cycling Myeloid,0.133243191283477,0,> 0.05
BILE ACID METABOLISM,DCs,-0.530055987451007,0,> 0.05
BILE ACID METABOLISM,Endothelial ACKR1,-0.0955461693465527,0,> 0.05
BILE ACID METABOLISM,Endothelial CXCL12,-0.450500901303983,0,> 0.05
BILE ACID METABOLISM,Endothelial Lymphatic LYVE1,-0.327210469355347,0,0
BILE ACID METABOLISM,Endothelial RGS5,-0.130873480220947,0,> 0.05
BILE ACID METABOLISM,Luminal Progenitors,-0.144194618066139,NA,> 0.05
BILE ACID METABOLISM,Macrophage,-0.514203617490407,0,> 0.05
BILE ACID METABOLISM,Mature Luminal,-0.598459160827973,NA,> 0.05
BILE ACID METABOLISM,Monocyte,-0.191879737602983,0,> 0.05
BILE ACID METABOLISM,Myoepithelial,0.00203796178257747,NA,> 0.05
BILE ACID METABOLISM,NK cells,0.153072431657973,0,> 0.05
BILE ACID METABOLISM,NKT cells,-0.0946347935979863,0,> 0.05
BILE ACID METABOLISM,Plasmablasts,0.273083637822029,0,> 0.05
BILE ACID METABOLISM,PVL Differentiated,-0.381681088810587,0,> 0.05
BILE ACID METABOLISM,PVL Immature,-0.441063440234083,0,> 0.05
BILE ACID METABOLISM,T cells CD4+,-0.0529649317422625,0,> 0.05
BILE ACID METABOLISM,T cells CD8+,-0.292473647471531,0,> 0.05
CHOLESTEROL HOMEOSTASIS,B cells Memory,-0.319834917114712,0,> 0.05
CHOLESTEROL HOMEOSTASIS,B cells Naive,-0.212436758311415,NA,> 0.05
CHOLESTEROL HOMEOSTASIS,CAFs MSC iCAF-like,0.151212646494381,0,> 0.05
CHOLESTEROL HOMEOSTASIS,CAFs myCAF-like,-0.0193489617984785,0,> 0.05
CHOLESTEROL HOMEOSTASIS,Cancer Basal SC,0.0320477169944016,0,> 0.05
CHOLESTEROL HOMEOSTASIS,Cancer Cycling,0.412104721071452,0,> 0.05
CHOLESTEROL HOMEOSTASIS,Cancer Her2 SC,0.262762670517119,0,> 0.05
CHOLESTEROL HOMEOSTASIS,Cancer LumA SC,0.432692590898286,0,> 0.05
CHOLESTEROL HOMEOSTASIS,Cancer LumB SC,0.360026781249953,0,> 0.05
CHOLESTEROL HOMEOSTASIS,Cycling PVL,0.428395483462597,0,> 0.05
CHOLESTEROL HOMEOSTASIS,Cycling T-cells,0.223276684969488,0,0
CHOLESTEROL HOMEOSTASIS,Cycling Myeloid,0.115541526599715,0,> 0.05
CHOLESTEROL HOMEOSTASIS,DCs,0.348472758095852,0,> 0.05
CHOLESTEROL HOMEOSTASIS,Endothelial ACKR1,-0.327184294987538,0,> 0.05
CHOLESTEROL HOMEOSTASIS,Endothelial CXCL12,-0.674599610077568,0,> 0.05
CHOLESTEROL HOMEOSTASIS,Endothelial Lymphatic LYVE1,-0.0435179112694313,0,0
CHOLESTEROL HOMEOSTASIS,Endothelial RGS5,-0.23108980480116,0,> 0.05
CHOLESTEROL HOMEOSTASIS,Luminal Progenitors,-0.195956155857701,NA,> 0.05
CHOLESTEROL HOMEOSTASIS,Macrophage,0.0984911354296033,0,> 0.05
CHOLESTEROL HOMEOSTASIS,Mature Luminal,-0.176182380752234,NA,> 0.05
CHOLESTEROL HOMEOSTASIS,Monocyte,0.127995525989261,0,> 0.05
CHOLESTEROL HOMEOSTASIS,Myoepithelial,0.0931644172995435,NA,> 0.05
CHOLESTEROL HOMEOSTASIS,NK cells,-0.48818648312746,0,> 0.05
CHOLESTEROL HOMEOSTASIS,NKT cells,-0.102432552323892,0,> 0.05
CHOLESTEROL HOMEOSTASIS,Plasmablasts,-0.0946529218633766,0,> 0.05
CHOLESTEROL HOMEOSTASIS,PVL Differentiated,0.196904756173316,0,> 0.05
CHOLESTEROL HOMEOSTASIS,PVL Immature,-0.583863318674166,0,> 0.05
CHOLESTEROL HOMEOSTASIS,T cells CD4+,-0.280925532929995,0,> 0.05
CHOLESTEROL HOMEOSTASIS,T cells CD8+,-0.0633324428825499,0,> 0.05
COAGULATION,B cells Memory,-0.337314156320909,0,> 0.05
COAGULATION,B cells Naive,-0.221619595558701,NA,> 0.05
COAGULATION,CAFs MSC iCAF-like,0.161274389004413,0,> 0.05
COAGULATION,CAFs myCAF-like,0.304477010042766,0,> 0.05
COAGULATION,Cancer Basal SC,-0.0629272762479076,0,> 0.05
COAGULATION,Cancer Cycling,0.102731537771721,0,> 0.05
COAGULATION,Cancer Her2 SC,-0.250677335923489,0,> 0.05
COAGULATION,Cancer LumA SC,-0.251890207225739,0,> 0.05
COAGULATION,Cancer LumB SC,0.00268306337209058,0,> 0.05
COAGULATION,Cycling PVL,0.557716168380188,0,> 0.05
COAGULATION,Cycling T-cells,-0.158253202797808,0,0
COAGULATION,Cycling Myeloid,0.696752034995243,0,> 0.05
COAGULATION,DCs,-0.173408328740845,0,> 0.05
COAGULATION,Endothelial ACKR1,-0.462754468027167,0,> 0.05
COAGULATION,Endothelial CXCL12,0.171360265716029,0,> 0.05
COAGULATION,Endothelial Lymphatic LYVE1,-0.34273909755782,0,0
COAGULATION,Endothelial RGS5,-0.602085217006237,0,> 0.05
COAGULATION,Luminal Progenitors,-0.203439371153378,NA,> 0.05
COAGULATION,Macrophage,0.251016217794532,0,> 0.05
COAGULATION,Mature Luminal,0.412221369692702,NA,> 0.05
COAGULATION,Monocyte,-0.118583129858998,0,> 0.05
COAGULATION,Myoepithelial,-0.0348940399860368,NA,> 0.05
COAGULATION,NK cells,0.0614535055522975,0,> 0.05
COAGULATION,NKT cells,-0.179693220396193,0,> 0.05
COAGULATION,Plasmablasts,0.152247978406881,-1.74892346842129,0.00285928496393759
COAGULATION,PVL Differentiated,0.0878564258783849,0,> 0.05
COAGULATION,PVL Immature,-0.407481474414334,0,> 0.05
COAGULATION,T cells CD4+,-0.206778482849307,-1.56291761388783,0.0474057281572308
COAGULATION,T cells CD8+,0.0596139150219858,0,> 0.05
COMPLEMENT,B cells Memory,0.0515543766155627,0,> 0.05
COMPLEMENT,B cells Naive,-0.416066597061224,NA,> 0.05
COMPLEMENT,CAFs MSC iCAF-like,0.0324174783131821,0,> 0.05
COMPLEMENT,CAFs myCAF-like,0.0317002640503888,0,> 0.05
COMPLEMENT,Cancer Basal SC,0.424852865610054,0,> 0.05
COMPLEMENT,Cancer Cycling,0.240355254251203,0,> 0.05
COMPLEMENT,Cancer Her2 SC,-0.0236128103489154,0,> 0.05
COMPLEMENT,Cancer LumA SC,0.033185268872777,0,> 0.05
COMPLEMENT,Cancer LumB SC,0.216749990771719,0,> 0.05
COMPLEMENT,Cycling PVL,0.414588562871341,0,> 0.05
COMPLEMENT,Cycling T-cells,0.2561476653545,0,0
COMPLEMENT,Cycling Myeloid,0.427587994568576,0,> 0.05
COMPLEMENT,DCs,0.143706226611404,0,> 0.05
COMPLEMENT,Endothelial ACKR1,-0.427305479502554,0,> 0.05
COMPLEMENT,Endothelial CXCL12,-0.484138457473063,0,> 0.05
COMPLEMENT,Endothelial Lymphatic LYVE1,-0.381413703902669,0,0
COMPLEMENT,Endothelial RGS5,-0.244614200797819,0,> 0.05
COMPLEMENT,Luminal Progenitors,-0.531155857472386,NA,> 0.05
COMPLEMENT,Macrophage,0.0213749473270378,0,> 0.05
COMPLEMENT,Mature Luminal,0.0542867565329959,NA,> 0.05
COMPLEMENT,Monocyte,-0.168091998501831,0,> 0.05
COMPLEMENT,Myoepithelial,-0.168245101279506,NA,> 0.05
COMPLEMENT,NK cells,-0.116727596213405,0,> 0.05
COMPLEMENT,NKT cells,-0.642386888468904,0,> 0.05
COMPLEMENT,Plasmablasts,-0.120315281291455,0,> 0.05
COMPLEMENT,PVL Differentiated,0.215179947887201,0,> 0.05
COMPLEMENT,PVL Immature,-0.268957389324851,0,> 0.05
COMPLEMENT,T cells CD4+,0.0644692155988433,0,> 0.05
COMPLEMENT,T cells CD8+,-0.1536322988346,0,> 0.05
DNA REPAIR,B cells Memory,-0.426104375208925,0,> 0.05
DNA REPAIR,B cells Naive,-0.431966548032491,NA,> 0.05
DNA REPAIR,CAFs MSC iCAF-like,-0.0248218889586102,0,> 0.05
DNA REPAIR,CAFs myCAF-like,-0.0827835362630166,0,> 0.05
DNA REPAIR,Cancer Basal SC,-0.164921437437219,0,> 0.05
DNA REPAIR,Cancer Cycling,0.0189910876891422,0,> 0.05
DNA REPAIR,Cancer Her2 SC,-0.000936979507579405,0,> 0.05
DNA REPAIR,Cancer LumA SC,0.407923021163841,0,> 0.05
DNA REPAIR,Cancer LumB SC,0.084095687103163,0,> 0.05
DNA REPAIR,Cycling PVL,-0.253796631439442,0,> 0.05
DNA REPAIR,Cycling T-cells,0.0927308153312964,0,0
DNA REPAIR,Cycling Myeloid,0.22291405362699,0,> 0.05
DNA REPAIR,DCs,0.0476371026918187,0,> 0.05
DNA REPAIR,Endothelial ACKR1,-0.267191156282388,0,> 0.05
DNA REPAIR,Endothelial CXCL12,-0.415029728743121,0,> 0.05
DNA REPAIR,Endothelial Lymphatic LYVE1,0.235888705698622,0,0
DNA REPAIR,Endothelial RGS5,-0.073260481086307,0,> 0.05
DNA REPAIR,Luminal Progenitors,-0.543552399948253,NA,> 0.05
DNA REPAIR,Macrophage,-0.0944090701655833,0,> 0.05
DNA REPAIR,Mature Luminal,-0.546153128899122,NA,> 0.05
DNA REPAIR,Monocyte,-0.177433650504731,0,> 0.05
DNA REPAIR,Myoepithelial,-0.415178881062277,NA,> 0.05
DNA REPAIR,NK cells,-0.294471155141874,0,> 0.05
DNA REPAIR,NKT cells,-0.346268337608365,0,> 0.05
DNA REPAIR,Plasmablasts,-0.276787091506507,0,> 0.05
DNA REPAIR,PVL Differentiated,-0.482865069943539,0,> 0.05
DNA REPAIR,PVL Immature,-0.471110402821813,0,> 0.05
DNA REPAIR,T cells CD4+,-0.476814525485824,-1.67785739942749,0.00191893650188239
DNA REPAIR,T cells CD8+,-0.354590103731643,0,> 0.05
E2F TARGETS,B cells Memory,-0.318910574001511,0,> 0.05
E2F TARGETS,B cells Naive,-0.332551466525009,NA,> 0.05
E2F TARGETS,CAFs MSC iCAF-like,-0.707333565203931,0,> 0.05
E2F TARGETS,CAFs myCAF-like,-0.489022623984341,0,> 0.05
E2F TARGETS,Cancer Basal SC,-0.298099132029397,0,> 0.05
E2F TARGETS,Cancer Cycling,0.00684054962849058,0,> 0.05
E2F TARGETS,Cancer Her2 SC,0.00576029344655958,0,> 0.05
E2F TARGETS,Cancer LumA SC,-0.520296533992344,0,> 0.05
E2F TARGETS,Cancer LumB SC,-0.438059746243814,0,> 0.05
E2F TARGETS,Cycling PVL,-0.125279607350733,0,> 0.05
E2F TARGETS,Cycling T-cells,0.211037325066949,0,0
E2F TARGETS,Cycling Myeloid,0.348723119308045,0,> 0.05
E2F TARGETS,DCs,0.0599436535209669,0,> 0.05
E2F TARGETS,Endothelial ACKR1,-0.716554637507464,0,> 0.05
E2F TARGETS,Endothelial CXCL12,-0.647915414642546,0,> 0.05
E2F TARGETS,Endothelial Lymphatic LYVE1,0.12291873288141,0,0
E2F TARGETS,Endothelial RGS5,-0.206670030977756,0,> 0.05
E2F TARGETS,Luminal Progenitors,-0.4092739821245,NA,> 0.05
E2F TARGETS,Macrophage,-0.243386093421408,0,> 0.05
E2F TARGETS,Mature Luminal,-0.287800588224421,NA,> 0.05
E2F TARGETS,Monocyte,-0.210106931994625,0,> 0.05
E2F TARGETS,Myoepithelial,-0.0431199810263122,NA,> 0.05
E2F TARGETS,NK cells,-0.190540475742923,0,> 0.05
E2F TARGETS,NKT cells,-0.406870915923317,0,> 0.05
E2F TARGETS,Plasmablasts,0.193072434994982,0,> 0.05
E2F TARGETS,PVL Differentiated,-0.479961901387615,0,> 0.05
E2F TARGETS,PVL Immature,-0.686858929053983,0,> 0.05
E2F TARGETS,T cells CD4+,-0.303914541894,0,> 0.05
E2F TARGETS,T cells CD8+,-0.388979532360941,-1.9016398080111,2.74310582531557e-07
EPITHELIAL MESENCHYMAL TRANSITION,B cells Memory,-0.154341406232491,0,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,B cells Naive,-0.0965056020174826,NA,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,CAFs MSC iCAF-like,0.405700556508303,2.1569519567842,1.30366051735968e-07
EPITHELIAL MESENCHYMAL TRANSITION,CAFs myCAF-like,0.52103619819297,2.08498280987343,1.75802517038958e-06
EPITHELIAL MESENCHYMAL TRANSITION,Cancer Basal SC,-0.183282931461452,0,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,Cancer Cycling,0.0142017553517791,0,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,Cancer Her2 SC,-0.0094167156036815,0,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,Cancer LumA SC,-0.202670815819649,0,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,Cancer LumB SC,0.0615427990096009,0,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,Cycling PVL,0.429407144983658,2.71930131875477,1.29552138591664e-11
EPITHELIAL MESENCHYMAL TRANSITION,Cycling T-cells,0.0791416803169176,0,0
EPITHELIAL MESENCHYMAL TRANSITION,Cycling Myeloid,0.473735471138201,0,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,DCs,0.678204113653642,0,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,Endothelial ACKR1,0.34809837985986,0,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,Endothelial CXCL12,0.405746358599978,0,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,Endothelial Lymphatic LYVE1,0.443918615319176,0,0
EPITHELIAL MESENCHYMAL TRANSITION,Endothelial RGS5,-0.0405718905712084,0,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,Luminal Progenitors,0.379123834216583,NA,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,Macrophage,0.716460618442987,0,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,Mature Luminal,0.355885474390843,NA,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,Monocyte,0.415068869057148,0,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,Myoepithelial,-0.0481243005546969,NA,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,NK cells,0.28084747335418,0,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,NKT cells,0.549966614987359,0,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,Plasmablasts,-0.166161714817217,-2.05922153439066,1.54777369949269e-07
EPITHELIAL MESENCHYMAL TRANSITION,PVL Differentiated,0.311978457797774,2.33108580338739,1.80284955125483e-09
EPITHELIAL MESENCHYMAL TRANSITION,PVL Immature,0.196251626395045,0,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,T cells CD4+,0.44001156209877,0,> 0.05
EPITHELIAL MESENCHYMAL TRANSITION,T cells CD8+,0.347019060642543,0,> 0.05
ESTROGEN RESPONSE EARLY,B cells Memory,-0.0799379477239693,0,> 0.05
ESTROGEN RESPONSE EARLY,B cells Naive,-0.167657496080555,NA,> 0.05
ESTROGEN RESPONSE EARLY,CAFs MSC iCAF-like,0.0425378068731612,0,> 0.05
ESTROGEN RESPONSE EARLY,CAFs myCAF-like,0.371654780624532,0,> 0.05
ESTROGEN RESPONSE EARLY,Cancer Basal SC,-0.0240852285762701,0,> 0.05
ESTROGEN RESPONSE EARLY,Cancer Cycling,0.375962873172976,0,> 0.05
ESTROGEN RESPONSE EARLY,Cancer Her2 SC,0.221357266314199,0,> 0.05
ESTROGEN RESPONSE EARLY,Cancer LumA SC,0.461303243615298,0,> 0.05
ESTROGEN RESPONSE EARLY,Cancer LumB SC,0.272545158706846,0,> 0.05
ESTROGEN RESPONSE EARLY,Cycling PVL,0.286589178099727,1.79232561923772,0.00173930019651123
ESTROGEN RESPONSE EARLY,Cycling T-cells,0.34398218804635,0,0
ESTROGEN RESPONSE EARLY,Cycling Myeloid,-0.254811773819863,0,> 0.05
ESTROGEN RESPONSE EARLY,DCs,0.676113780228751,0,> 0.05
ESTROGEN RESPONSE EARLY,Endothelial ACKR1,0.203657890772855,0,> 0.05
ESTROGEN RESPONSE EARLY,Endothelial CXCL12,0.0130638563758562,0,> 0.05
ESTROGEN RESPONSE EARLY,Endothelial Lymphatic LYVE1,-0.0584741250506064,0,0
ESTROGEN RESPONSE EARLY,Endothelial RGS5,0.258221609124424,0,> 0.05
ESTROGEN RESPONSE EARLY,Luminal Progenitors,-0.101286034361953,NA,> 0.05
ESTROGEN RESPONSE EARLY,Macrophage,0.252470195222177,0,> 0.05
ESTROGEN RESPONSE EARLY,Mature Luminal,-0.250256869413164,NA,> 0.05
ESTROGEN RESPONSE EARLY,Monocyte,0.383691204641031,0,> 0.05
ESTROGEN RESPONSE EARLY,Myoepithelial,0.475847846110432,NA,> 0.05
ESTROGEN RESPONSE EARLY,NK cells,0.479102986363773,0,> 0.05
ESTROGEN RESPONSE EARLY,NKT cells,0.780508757077039,0,> 0.05
ESTROGEN RESPONSE EARLY,Plasmablasts,0.108440189641035,-1.86490971239177,2.10588319503432e-05
ESTROGEN RESPONSE EARLY,PVL Differentiated,0.418652063580686,0,> 0.05
ESTROGEN RESPONSE EARLY,PVL Immature,0.247285481205698,0,> 0.05
ESTROGEN RESPONSE EARLY,T cells CD4+,0.104933264975376,0,> 0.05
ESTROGEN RESPONSE EARLY,T cells CD8+,0.626599975222458,0,> 0.05
ESTROGEN RESPONSE LATE,B cells Memory,0.0296895216885231,0,> 0.05
ESTROGEN RESPONSE LATE,B cells Naive,0.0349620937517941,NA,> 0.05
ESTROGEN RESPONSE LATE,CAFs MSC iCAF-like,-0.00791320501697228,0,> 0.05
ESTROGEN RESPONSE LATE,CAFs myCAF-like,0.15477172405456,0,> 0.05
ESTROGEN RESPONSE LATE,Cancer Basal SC,-0.0182596836522233,0,> 0.05
ESTROGEN RESPONSE LATE,Cancer Cycling,0.127834012556494,0,> 0.05
ESTROGEN RESPONSE LATE,Cancer Her2 SC,0.0725577813024693,0,> 0.05
ESTROGEN RESPONSE LATE,Cancer LumA SC,0.34691321373778,0,> 0.05
ESTROGEN RESPONSE LATE,Cancer LumB SC,0.141235555875293,0,> 0.05
ESTROGEN RESPONSE LATE,Cycling PVL,0.449137890268011,0,> 0.05
ESTROGEN RESPONSE LATE,Cycling T-cells,0.467681089371334,0,0
ESTROGEN RESPONSE LATE,Cycling Myeloid,0.0724803651607473,0,> 0.05
ESTROGEN RESPONSE LATE,DCs,0.466786040299277,0,> 0.05
ESTROGEN RESPONSE LATE,Endothelial ACKR1,-0.102369338864769,0,> 0.05
ESTROGEN RESPONSE LATE,Endothelial CXCL12,-0.398826872010702,-1.76767596210784,7.38399625828058e-05
ESTROGEN RESPONSE LATE,Endothelial Lymphatic LYVE1,0.091260663497292,0,0
ESTROGEN RESPONSE LATE,Endothelial RGS5,0.0643098219712114,0,> 0.05
ESTROGEN RESPONSE LATE,Luminal Progenitors,-0.193317767426258,NA,> 0.05
ESTROGEN RESPONSE LATE,Macrophage,0.364145040224091,0,> 0.05
ESTROGEN RESPONSE LATE,Mature Luminal,-0.284512321357749,NA,> 0.05
ESTROGEN RESPONSE LATE,Monocyte,0.247512732150994,0,> 0.05
ESTROGEN RESPONSE LATE,Myoepithelial,-0.0995432808038543,NA,> 0.05
ESTROGEN RESPONSE LATE,NK cells,0.0613245252574637,0,> 0.05
ESTROGEN RESPONSE LATE,NKT cells,0.407982702270957,0,> 0.05
ESTROGEN RESPONSE LATE,Plasmablasts,-0.348325547787888,-1.62230594725971,0.00329545954187164
ESTROGEN RESPONSE LATE,PVL Differentiated,-0.0277475083271386,0,> 0.05
ESTROGEN RESPONSE LATE,PVL Immature,-0.328503332983401,0,> 0.05
ESTROGEN RESPONSE LATE,T cells CD4+,0.060659278951597,0,> 0.05
ESTROGEN RESPONSE LATE,T cells CD8+,0.320277985660712,0,> 0.05
FATTY ACID METABOLISM,B cells Memory,-0.178649579450503,0,> 0.05
FATTY ACID METABOLISM,B cells Naive,-0.0390469260926131,NA,> 0.05
FATTY ACID METABOLISM,CAFs MSC iCAF-like,-0.562091994400736,0,> 0.05
FATTY ACID METABOLISM,CAFs myCAF-like,-0.539324742643887,0,> 0.05
FATTY ACID METABOLISM,Cancer Basal SC,0.292647707563984,0,> 0.05
FATTY ACID METABOLISM,Cancer Cycling,0.231308715554937,0,> 0.05
FATTY ACID METABOLISM,Cancer Her2 SC,0.430773352069433,0,> 0.05
FATTY ACID METABOLISM,Cancer LumA SC,0.477659967497239,0,> 0.05
FATTY ACID METABOLISM,Cancer LumB SC,0.374721610829774,0,> 0.05
FATTY ACID METABOLISM,Cycling PVL,-0.172770177715689,0,> 0.05
FATTY ACID METABOLISM,Cycling T-cells,-0.281819783591277,0,0
FATTY ACID METABOLISM,Cycling Myeloid,0.188538879789327,0,> 0.05
FATTY ACID METABOLISM,DCs,0.161095322445594,0,> 0.05
FATTY ACID METABOLISM,Endothelial ACKR1,-0.589023745383457,-1.82565867568136,1.17856339257344e-05
FATTY ACID METABOLISM,Endothelial CXCL12,-0.714073276097879,-1.86886219254456,2.51452568371052e-05
FATTY ACID METABOLISM,Endothelial Lymphatic LYVE1,-0.524101844488549,0,0
FATTY ACID METABOLISM,Endothelial RGS5,-0.337512809290902,-1.67289472698618,0.00151824286013198
FATTY ACID METABOLISM,Luminal Progenitors,-0.423198430018023,NA,> 0.05
FATTY ACID METABOLISM,Macrophage,-0.205466997786182,-2.0633751018368,3.08256622305625e-06
FATTY ACID METABOLISM,Mature Luminal,-0.23557155587825,NA,> 0.05
FATTY ACID METABOLISM,Monocyte,-0.267005223237102,-1.87766399140699,0.000236751388508754
FATTY ACID METABOLISM,Myoepithelial,0.039820806104378,NA,> 0.05
FATTY ACID METABOLISM,NK cells,-0.0620064510535863,0,> 0.05
FATTY ACID METABOLISM,NKT cells,-0.26954225219409,0,> 0.05
FATTY ACID METABOLISM,Plasmablasts,-0.3077258470686,-1.81711853132755,0.000360434609525733
FATTY ACID METABOLISM,PVL Differentiated,-0.635688422159201,0,> 0.05
FATTY ACID METABOLISM,PVL Immature,-0.838174323813868,-2.00508656301202,5.37911851047255e-06
FATTY ACID METABOLISM,T cells CD4+,-0.174162103513342,-1.67762531193368,0.00177102244471207
FATTY ACID METABOLISM,T cells CD8+,-0.0987012168425729,0,> 0.05
G2M CHECKPOINT,B cells Memory,0.203918817201501,0,> 0.05
G2M CHECKPOINT,B cells Naive,0.0450154381466552,NA,> 0.05
G2M CHECKPOINT,CAFs MSC iCAF-like,-0.119915521607495,0,> 0.05
G2M CHECKPOINT,CAFs myCAF-like,-0.00920943342237643,0,> 0.05
G2M CHECKPOINT,Cancer Basal SC,0.138268070802481,0,> 0.05
G2M CHECKPOINT,Cancer Cycling,0.111297088431608,0,> 0.05
G2M CHECKPOINT,Cancer Her2 SC,0.105149327871488,0,> 0.05
G2M CHECKPOINT,Cancer LumA SC,0.141874975881689,0,> 0.05
G2M CHECKPOINT,Cancer LumB SC,-0.0192831750377303,0,> 0.05
G2M CHECKPOINT,Cycling PVL,0.270292177220897,0,> 0.05
G2M CHECKPOINT,Cycling T-cells,0.283194293710302,0,0
G2M CHECKPOINT,Cycling Myeloid,0.081138800326761,0,> 0.05
G2M CHECKPOINT,DCs,0.369972490534746,0,> 0.05
G2M CHECKPOINT,Endothelial ACKR1,-0.0477836209101846,0,> 0.05
G2M CHECKPOINT,Endothelial CXCL12,-0.162429846643826,0,> 0.05
G2M CHECKPOINT,Endothelial Lymphatic LYVE1,0.170631997135965,0,0
G2M CHECKPOINT,Endothelial RGS5,0.136210099375188,0,> 0.05
G2M CHECKPOINT,Luminal Progenitors,0.0252039325230035,NA,> 0.05
G2M CHECKPOINT,Macrophage,0.410868013824614,0,> 0.05
G2M CHECKPOINT,Mature Luminal,-0.477640313880188,NA,> 0.05
G2M CHECKPOINT,Monocyte,0.221344036072475,0,> 0.05
G2M CHECKPOINT,Myoepithelial,-0.0524894576211763,NA,> 0.05
G2M CHECKPOINT,NK cells,0.0115529231652387,0,> 0.05
G2M CHECKPOINT,NKT cells,-0.0218187484343657,0,> 0.05
G2M CHECKPOINT,Plasmablasts,0.433718334540564,0,> 0.05
G2M CHECKPOINT,PVL Differentiated,0.101934488530494,0,> 0.05
G2M CHECKPOINT,PVL Immature,-0.199183379444815,0,> 0.05
G2M CHECKPOINT,T cells CD4+,0.104812831903312,0,> 0.05
G2M CHECKPOINT,T cells CD8+,0.00146335576799246,0,> 0.05
GLYCOLYSIS,B cells Memory,-0.541898402899174,0,> 0.05
GLYCOLYSIS,B cells Naive,-0.393451665692982,NA,> 0.05
GLYCOLYSIS,CAFs MSC iCAF-like,-0.196231249567881,0,> 0.05
GLYCOLYSIS,CAFs myCAF-like,0.397447088592727,0,> 0.05
GLYCOLYSIS,Cancer Basal SC,-0.130916179553266,0,> 0.05
GLYCOLYSIS,Cancer Cycling,0.129496688627535,0,> 0.05
GLYCOLYSIS,Cancer Her2 SC,0.311076501690026,0,> 0.05
GLYCOLYSIS,Cancer LumA SC,0.347869515442226,0,> 0.05
GLYCOLYSIS,Cancer LumB SC,0.218887346350588,0,> 0.05
GLYCOLYSIS,Cycling PVL,0.158062520120443,0,> 0.05
GLYCOLYSIS,Cycling T-cells,-0.145385550267746,0,0
GLYCOLYSIS,Cycling Myeloid,0.11291453253818,0,> 0.05
GLYCOLYSIS,DCs,-0.220618357470338,0,> 0.05
GLYCOLYSIS,Endothelial ACKR1,-0.45324401344834,0,> 0.05
GLYCOLYSIS,Endothelial CXCL12,-0.676827353303752,0,> 0.05
GLYCOLYSIS,Endothelial Lymphatic LYVE1,-0.877856701421781,0,0
GLYCOLYSIS,Endothelial RGS5,-0.54940738254879,0,> 0.05
GLYCOLYSIS,Luminal Progenitors,-0.13070489574291,NA,> 0.05
GLYCOLYSIS,Macrophage,-0.303985240627337,0,> 0.05
GLYCOLYSIS,Mature Luminal,-0.303301961748275,NA,> 0.05
GLYCOLYSIS,Monocyte,-0.27268617723592,0,> 0.05
GLYCOLYSIS,Myoepithelial,-0.0954244364487993,NA,> 0.05
GLYCOLYSIS,NK cells,-0.50340633322436,0,> 0.05
GLYCOLYSIS,NKT cells,0.0437492282226414,0,> 0.05
GLYCOLYSIS,Plasmablasts,-0.474766336226292,-1.60690248026413,0.00403009768341599
GLYCOLYSIS,PVL Differentiated,-0.339221862942959,0,> 0.05
GLYCOLYSIS,PVL Immature,-0.339899912752577,0,> 0.05
GLYCOLYSIS,T cells CD4+,-0.531736047123109,-1.67275897553287,0.00103446044230328
GLYCOLYSIS,T cells CD8+,-0.454514714766479,0,> 0.05
HEDGEHOG SIGNALING,B cells Memory,-0.310353357909952,0,> 0.05
HEDGEHOG SIGNALING,B cells Naive,-0.297757070451927,NA,> 0.05
HEDGEHOG SIGNALING,CAFs MSC iCAF-like,0.2462882391101,0,> 0.05
HEDGEHOG SIGNALING,CAFs myCAF-like,0.495618556612129,0,> 0.05
HEDGEHOG SIGNALING,Cancer Basal SC,0.378035744510433,0,> 0.05
HEDGEHOG SIGNALING,Cancer Cycling,0.127898162611987,0,> 0.05
HEDGEHOG SIGNALING,Cancer Her2 SC,0.0826315322506721,0,> 0.05
HEDGEHOG SIGNALING,Cancer LumA SC,-0.288730613238052,0,> 0.05
HEDGEHOG SIGNALING,Cancer LumB SC,0.000716756828534619,0,> 0.05
HEDGEHOG SIGNALING,Cycling PVL,0.252851798105574,0,> 0.05
HEDGEHOG SIGNALING,Cycling T-cells,-0.212708506948714,0,0
HEDGEHOG SIGNALING,Cycling Myeloid,0.584644988346025,0,> 0.05
HEDGEHOG SIGNALING,DCs,0.171128565246711,0,> 0.05
HEDGEHOG SIGNALING,Endothelial ACKR1,0.142007133753898,0,> 0.05
HEDGEHOG SIGNALING,Endothelial CXCL12,0.490949365848075,0,> 0.05
HEDGEHOG SIGNALING,Endothelial Lymphatic LYVE1,0.413246113674094,0,0
HEDGEHOG SIGNALING,Endothelial RGS5,-0.0621437644437314,0,> 0.05
HEDGEHOG SIGNALING,Luminal Progenitors,0.526890983360634,NA,> 0.05
HEDGEHOG SIGNALING,Macrophage,0.461915097413349,0,> 0.05
HEDGEHOG SIGNALING,Mature Luminal,0.597233689356787,NA,> 0.05
HEDGEHOG SIGNALING,Monocyte,0.622891145924276,0,> 0.05
HEDGEHOG SIGNALING,Myoepithelial,0.636013526825148,NA,> 0.05
HEDGEHOG SIGNALING,NK cells,0.580833102915494,0,> 0.05
HEDGEHOG SIGNALING,NKT cells,-0.039956011368817,0,> 0.05
HEDGEHOG SIGNALING,Plasmablasts,0.51149501819133,0,> 0.05
HEDGEHOG SIGNALING,PVL Differentiated,0.37101005741475,0,> 0.05
HEDGEHOG SIGNALING,PVL Immature,0.327110422555752,0,> 0.05
HEDGEHOG SIGNALING,T cells CD4+,0.400322988099036,0,> 0.05
HEDGEHOG SIGNALING,T cells CD8+,0.494825132246748,0,> 0.05
HEME METABOLISM,B cells Memory,-0.515063723834424,0,> 0.05
HEME METABOLISM,B cells Naive,-0.430688733465619,NA,> 0.05
HEME METABOLISM,CAFs MSC iCAF-like,-0.501253894797613,0,> 0.05
HEME METABOLISM,CAFs myCAF-like,-0.199975385277473,0,> 0.05
HEME METABOLISM,Cancer Basal SC,-0.409681520216254,0,> 0.05
HEME METABOLISM,Cancer Cycling,0.32065207842324,0,> 0.05
HEME METABOLISM,Cancer Her2 SC,0.111428319763984,0,> 0.05
HEME METABOLISM,Cancer LumA SC,0.0994307442666045,0,> 0.05
HEME METABOLISM,Cancer LumB SC,0.215607189155004,0,> 0.05
HEME METABOLISM,Cycling PVL,0.209793354666842,0,> 0.05
HEME METABOLISM,Cycling T-cells,0.445874850549186,0,0
HEME METABOLISM,Cycling Myeloid,0.29725534303999,0,> 0.05
HEME METABOLISM,DCs,0.56789912052012,0,> 0.05
HEME METABOLISM,Endothelial ACKR1,-0.431130508955839,0,> 0.05
HEME METABOLISM,Endothelial CXCL12,-0.0624649772994972,0,> 0.05
HEME METABOLISM,Endothelial Lymphatic LYVE1,-0.463754957834582,0,0
HEME METABOLISM,Endothelial RGS5,-0.102895324141152,0,> 0.05
HEME METABOLISM,Luminal Progenitors,0.00401913542815035,NA,> 0.05
HEME METABOLISM,Macrophage,-0.0973309236303827,0,> 0.05
HEME METABOLISM,Mature Luminal,-0.480376815420346,NA,> 0.05
HEME METABOLISM,Monocyte,0.126262669736104,0,> 0.05
HEME METABOLISM,Myoepithelial,0.469061035125986,NA,> 0.05
HEME METABOLISM,NK cells,0.0301596934058663,0,> 0.05
HEME METABOLISM,NKT cells,0.0518017556612835,0,> 0.05
HEME METABOLISM,Plasmablasts,0.0785909281357585,0,> 0.05
HEME METABOLISM,PVL Differentiated,-0.373306321900962,0,> 0.05
HEME METABOLISM,PVL Immature,-0.556408775856467,0,> 0.05
HEME METABOLISM,T cells CD4+,0.0194338363561283,0,> 0.05
HEME METABOLISM,T cells CD8+,0.120442570065613,0,> 0.05
HYPOXIA,B cells Memory,0.626440979148882,0,> 0.05
HYPOXIA,B cells Naive,0.341328724423557,NA,> 0.05
HYPOXIA,CAFs MSC iCAF-like,-0.0343132796553301,0,> 0.05
HYPOXIA,CAFs myCAF-like,0.518984355722918,0,> 0.05
HYPOXIA,Cancer Basal SC,-0.0788490326096129,0,> 0.05
HYPOXIA,Cancer Cycling,0.276297528476692,0,> 0.05
HYPOXIA,Cancer Her2 SC,-0.0252614160777454,0,> 0.05
HYPOXIA,Cancer LumA SC,0.441279145757133,0,> 0.05
HYPOXIA,Cancer LumB SC,0.14976214588309,0,> 0.05
HYPOXIA,Cycling PVL,0.431223086848436,1.89147992251845,0.000376377777551093
HYPOXIA,Cycling T-cells,0.346133119593146,0,0
HYPOXIA,Cycling Myeloid,0.560985385999306,0,> 0.05
HYPOXIA,DCs,0.597815872290701,0,> 0.05
HYPOXIA,Endothelial ACKR1,0.079130439047646,0,> 0.05
HYPOXIA,Endothelial CXCL12,-0.167978488487475,0,> 0.05
HYPOXIA,Endothelial Lymphatic LYVE1,0.162178733156904,0,0
HYPOXIA,Endothelial RGS5,0.097226146322013,0,> 0.05
HYPOXIA,Luminal Progenitors,-0.103143617894129,NA,> 0.05
HYPOXIA,Macrophage,0.608490180326457,0,> 0.05
HYPOXIA,Mature Luminal,-0.287028964798515,NA,> 0.05
HYPOXIA,Monocyte,0.415024949308512,0,> 0.05
HYPOXIA,Myoepithelial,-0.0794477193383018,NA,> 0.05
HYPOXIA,NK cells,0.134727672141568,0,> 0.05
HYPOXIA,NKT cells,0.299044558981338,0,> 0.05
HYPOXIA,Plasmablasts,-0.318197421616669,0,> 0.05
HYPOXIA,PVL Differentiated,0.00855790222241121,0,> 0.05
HYPOXIA,PVL Immature,-0.212378265444344,0,> 0.05
HYPOXIA,T cells CD4+,0.358018244554229,0,> 0.05
HYPOXIA,T cells CD8+,0.301599121350748,0,> 0.05
IL2 STAT5 SIGNALING,B cells Memory,0.71853758117907,0,> 0.05
IL2 STAT5 SIGNALING,B cells Naive,0.43360224936084,NA,> 0.05
IL2 STAT5 SIGNALING,CAFs MSC iCAF-like,0.64691073157572,0,> 0.05
IL2 STAT5 SIGNALING,CAFs myCAF-like,0.689055674521792,0,> 0.05
IL2 STAT5 SIGNALING,Cancer Basal SC,-0.149329488541233,0,> 0.05
IL2 STAT5 SIGNALING,Cancer Cycling,0.329137867819205,0,> 0.05
IL2 STAT5 SIGNALING,Cancer Her2 SC,0.346631105885048,0,> 0.05
IL2 STAT5 SIGNALING,Cancer LumA SC,0.378325834366343,0,> 0.05
IL2 STAT5 SIGNALING,Cancer LumB SC,0.366697404169922,0,> 0.05
IL2 STAT5 SIGNALING,Cycling PVL,0.600750936064429,0,> 0.05
IL2 STAT5 SIGNALING,Cycling T-cells,0.633584991685102,0,0
IL2 STAT5 SIGNALING,Cycling Myeloid,0.653950084994315,0,> 0.05
IL2 STAT5 SIGNALING,DCs,0.727614051584615,0,> 0.05
IL2 STAT5 SIGNALING,Endothelial ACKR1,0.217728644313951,0,> 0.05
IL2 STAT5 SIGNALING,Endothelial CXCL12,0.410960578388516,0,> 0.05
IL2 STAT5 SIGNALING,Endothelial Lymphatic LYVE1,0.807234186647291,0,0
IL2 STAT5 SIGNALING,Endothelial RGS5,0.578242505054855,0,> 0.05
IL2 STAT5 SIGNALING,Luminal Progenitors,0.434014870931467,NA,> 0.05
IL2 STAT5 SIGNALING,Macrophage,0.597267249905803,0,> 0.05
IL2 STAT5 SIGNALING,Mature Luminal,-0.0787280230807233,NA,> 0.05
IL2 STAT5 SIGNALING,Monocyte,0.27534287861417,0,> 0.05
IL2 STAT5 SIGNALING,Myoepithelial,0.577401078277014,NA,> 0.05
IL2 STAT5 SIGNALING,NK cells,0.0455011183855528,0,> 0.05
IL2 STAT5 SIGNALING,NKT cells,0.365029885862267,0,> 0.05
IL2 STAT5 SIGNALING,Plasmablasts,0.502491395354541,0,> 0.05
IL2 STAT5 SIGNALING,PVL Differentiated,0.482209936273944,0,> 0.05
IL2 STAT5 SIGNALING,PVL Immature,0.36946845192217,0,> 0.05
IL2 STAT5 SIGNALING,T cells CD4+,0.534553536314716,1.6594255016829,0.000878024282348273
IL2 STAT5 SIGNALING,T cells CD8+,0.373133017849566,0,> 0.05
IL6 JAK STAT3 SIGNALING,B cells Memory,0.179733971968085,0,> 0.05
IL6 JAK STAT3 SIGNALING,B cells Naive,0.339584751664208,NA,> 0.05
IL6 JAK STAT3 SIGNALING,CAFs MSC iCAF-like,-0.0528114275567502,0,> 0.05
IL6 JAK STAT3 SIGNALING,CAFs myCAF-like,-0.0238533507488777,0,> 0.05
IL6 JAK STAT3 SIGNALING,Cancer Basal SC,-0.03924058059248,0,> 0.05
IL6 JAK STAT3 SIGNALING,Cancer Cycling,-0.0582802531637778,0,> 0.05
IL6 JAK STAT3 SIGNALING,Cancer Her2 SC,-0.0927346714704021,0,> 0.05
IL6 JAK STAT3 SIGNALING,Cancer LumA SC,-0.293561469801213,0,> 0.05
IL6 JAK STAT3 SIGNALING,Cancer LumB SC,-0.222718593050028,0,> 0.05
IL6 JAK STAT3 SIGNALING,Cycling PVL,0.316489729924331,0,> 0.05
IL6 JAK STAT3 SIGNALING,Cycling T-cells,0.283806932759386,0,0
IL6 JAK STAT3 SIGNALING,Cycling Myeloid,-0.0850305845596953,0,> 0.05
IL6 JAK STAT3 SIGNALING,DCs,0.350429688689263,0,> 0.05
IL6 JAK STAT3 SIGNALING,Endothelial ACKR1,-0.586429606724211,0,> 0.05
IL6 JAK STAT3 SIGNALING,Endothelial CXCL12,-0.573092159484307,0,> 0.05
IL6 JAK STAT3 SIGNALING,Endothelial Lymphatic LYVE1,0.175653206413219,0,0
IL6 JAK STAT3 SIGNALING,Endothelial RGS5,-0.342346944176348,0,> 0.05
IL6 JAK STAT3 SIGNALING,Luminal Progenitors,0.148564643281707,NA,> 0.05
IL6 JAK STAT3 SIGNALING,Macrophage,0.0624766923255937,0,> 0.05
IL6 JAK STAT3 SIGNALING,Mature Luminal,-0.169942289001256,NA,> 0.05
IL6 JAK STAT3 SIGNALING,Monocyte,-0.0610173240305032,0,> 0.05
IL6 JAK STAT3 SIGNALING,Myoepithelial,0.452486762021959,NA,> 0.05
IL6 JAK STAT3 SIGNALING,NK cells,-0.18135295546952,0,> 0.05
IL6 JAK STAT3 SIGNALING,NKT cells,0.155602022187938,0,> 0.05
IL6 JAK STAT3 SIGNALING,Plasmablasts,0.0530365575823254,0,> 0.05
IL6 JAK STAT3 SIGNALING,PVL Differentiated,-0.149062394556975,0,> 0.05
IL6 JAK STAT3 SIGNALING,PVL Immature,-0.487014927398685,0,> 0.05
IL6 JAK STAT3 SIGNALING,T cells CD4+,0.129236096885165,0,> 0.05
IL6 JAK STAT3 SIGNALING,T cells CD8+,0.154704523662791,0,> 0.05
INFLAMMATORY RESPONSE,B cells Memory,0.697836710787021,0,> 0.05
INFLAMMATORY RESPONSE,B cells Naive,0.400382388735264,NA,> 0.05
INFLAMMATORY RESPONSE,CAFs MSC iCAF-like,0.627594241928054,0,> 0.05
INFLAMMATORY RESPONSE,CAFs myCAF-like,0.436635219821413,0,> 0.05
INFLAMMATORY RESPONSE,Cancer Basal SC,-0.285616285694882,0,> 0.05
INFLAMMATORY RESPONSE,Cancer Cycling,-0.150195729952767,0,> 0.05
INFLAMMATORY RESPONSE,Cancer Her2 SC,-0.332523117910355,0,> 0.05
INFLAMMATORY RESPONSE,Cancer LumA SC,-0.429692683479573,0,> 0.05
INFLAMMATORY RESPONSE,Cancer LumB SC,-0.232472269803352,0,> 0.05
INFLAMMATORY RESPONSE,Cycling PVL,0.536253323966524,0,> 0.05
INFLAMMATORY RESPONSE,Cycling T-cells,0.714658123630471,0,0
INFLAMMATORY RESPONSE,Cycling Myeloid,0.189076790365624,0,> 0.05
INFLAMMATORY RESPONSE,DCs,0.619090681096078,1.95426920731312,1.10586114731295e-05
INFLAMMATORY RESPONSE,Endothelial ACKR1,0.569355336815912,0,> 0.05
INFLAMMATORY RESPONSE,Endothelial CXCL12,0.575706090457964,0,> 0.05
INFLAMMATORY RESPONSE,Endothelial Lymphatic LYVE1,0.500095896609055,0,0
INFLAMMATORY RESPONSE,Endothelial RGS5,0.582360133206695,0,> 0.05
INFLAMMATORY RESPONSE,Luminal Progenitors,0.507283542117491,NA,> 0.05
INFLAMMATORY RESPONSE,Macrophage,0.305888518435938,0,> 0.05
INFLAMMATORY RESPONSE,Mature Luminal,0.397976146958934,NA,> 0.05
INFLAMMATORY RESPONSE,Monocyte,0.182510353392328,0,> 0.05
INFLAMMATORY RESPONSE,Myoepithelial,0.631719199881743,NA,> 0.05
INFLAMMATORY RESPONSE,NK cells,0.118222879734737,0,> 0.05
INFLAMMATORY RESPONSE,NKT cells,0.491381687512477,0,> 0.05
INFLAMMATORY RESPONSE,Plasmablasts,0.186320463561388,0,> 0.05
INFLAMMATORY RESPONSE,PVL Differentiated,0.696157690226759,0,> 0.05
INFLAMMATORY RESPONSE,PVL Immature,0.34924944838817,0,> 0.05
INFLAMMATORY RESPONSE,T cells CD4+,0.330276880673966,0,> 0.05
INFLAMMATORY RESPONSE,T cells CD8+,0.296304630512181,0,> 0.05
INTERFERON ALPHA RESPONSE,B cells Memory,0.119518595542477,0,> 0.05
INTERFERON ALPHA RESPONSE,B cells Naive,0.198956534572633,NA,> 0.05
INTERFERON ALPHA RESPONSE,CAFs MSC iCAF-like,-0.12443858565559,0,> 0.05
INTERFERON ALPHA RESPONSE,CAFs myCAF-like,-0.136984497744331,0,> 0.05
INTERFERON ALPHA RESPONSE,Cancer Basal SC,-0.532672872292901,-2.18507439723121,6.91880631477426e-07
INTERFERON ALPHA RESPONSE,Cancer Cycling,-0.334626380866656,-2.18654498543258,4.44562436003171e-06
INTERFERON ALPHA RESPONSE,Cancer Her2 SC,-0.666182368419569,-3.34562701749938,3.11153151247088e-16
INTERFERON ALPHA RESPONSE,Cancer LumA SC,-0.28585000209289,-1.99208093919361,0.000935263907464121
INTERFERON ALPHA RESPONSE,Cancer LumB SC,-0.246609056990548,-1.76192172859161,0.0100504974776168
INTERFERON ALPHA RESPONSE,Cycling PVL,-0.333437729687124,0,> 0.05
INTERFERON ALPHA RESPONSE,Cycling T-cells,-0.0815835784181251,0,0
INTERFERON ALPHA RESPONSE,Cycling Myeloid,-0.280133616860371,0,> 0.05
INTERFERON ALPHA RESPONSE,DCs,-0.326503814752347,0,> 0.05
INTERFERON ALPHA RESPONSE,Endothelial ACKR1,-0.28055913354406,-1.87241771622891,7.83769657274995e-05
INTERFERON ALPHA RESPONSE,Endothelial CXCL12,-0.577523048941415,-2.09260556599597,2.61936955722261e-06
INTERFERON ALPHA RESPONSE,Endothelial Lymphatic LYVE1,0.0181026416851608,0,0
INTERFERON ALPHA RESPONSE,Endothelial RGS5,-0.56947173562342,-1.834948755823,0.000162088066427936
INTERFERON ALPHA RESPONSE,Luminal Progenitors,-0.471822087361132,NA,> 0.05
INTERFERON ALPHA RESPONSE,Macrophage,-0.32234249044956,-2.38745327223005,1.1133271645061e-07
INTERFERON ALPHA RESPONSE,Mature Luminal,-0.139625982876253,NA,> 0.05
INTERFERON ALPHA RESPONSE,Monocyte,-0.465082922581834,-2.25167379980643,2.36960903073142e-06
INTERFERON ALPHA RESPONSE,Myoepithelial,-0.165992654955045,NA,> 0.05
INTERFERON ALPHA RESPONSE,NK cells,-0.163900754053773,0,> 0.05
INTERFERON ALPHA RESPONSE,NKT cells,-0.37596239121775,0,> 0.05
INTERFERON ALPHA RESPONSE,Plasmablasts,-0.312481954725683,0,> 0.05
INTERFERON ALPHA RESPONSE,PVL Differentiated,0.001036038669647,0,> 0.05
INTERFERON ALPHA RESPONSE,PVL Immature,-0.287844760893522,0,> 0.05
INTERFERON ALPHA RESPONSE,T cells CD4+,-0.204531805877372,-1.69052520581653,0.00274301319721273
INTERFERON ALPHA RESPONSE,T cells CD8+,-0.285432816052998,-2.04858713408021,1.540337051977e-06
INTERFERON GAMMA RESPONSE,B cells Memory,0.250848787276,0,> 0.05
INTERFERON GAMMA RESPONSE,B cells Naive,0.259295159827375,NA,> 0.05
INTERFERON GAMMA RESPONSE,CAFs MSC iCAF-like,-0.155189311641348,0,> 0.05
INTERFERON GAMMA RESPONSE,CAFs myCAF-like,-0.116571558340166,0,> 0.05
INTERFERON GAMMA RESPONSE,Cancer Basal SC,-0.61195121733325,-2.03517030335699,1.05099352989613e-07
INTERFERON GAMMA RESPONSE,Cancer Cycling,-0.440422381897575,-1.75934995356421,4.4052305031361e-05
INTERFERON GAMMA RESPONSE,Cancer Her2 SC,-0.66666889145006,0,> 0.05
INTERFERON GAMMA RESPONSE,Cancer LumA SC,-0.32423689798221,0,> 0.05
INTERFERON GAMMA RESPONSE,Cancer LumB SC,-0.432506108841073,-1.52912880953081,0.0286997371813249
INTERFERON GAMMA RESPONSE,Cycling PVL,-0.102004005998234,0,> 0.05
INTERFERON GAMMA RESPONSE,Cycling T-cells,-0.036678021638705,0,0
INTERFERON GAMMA RESPONSE,Cycling Myeloid,-0.192885071724253,-1.71124342960554,0.00489182611022443
INTERFERON GAMMA RESPONSE,DCs,-0.0981626803613327,0,> 0.05
INTERFERON GAMMA RESPONSE,Endothelial ACKR1,-0.474682927628533,-1.75307865242933,1.49296173954473e-05
INTERFERON GAMMA RESPONSE,Endothelial CXCL12,-0.608541239469877,-1.7449747601218,7.38399625828058e-05
INTERFERON GAMMA RESPONSE,Endothelial Lymphatic LYVE1,-0.0923484777958884,0,0
INTERFERON GAMMA RESPONSE,Endothelial RGS5,-0.478266643883066,-1.4529158317174,0.0146965289724762
INTERFERON GAMMA RESPONSE,Luminal Progenitors,-0.41777909594098,NA,> 0.05
INTERFERON GAMMA RESPONSE,Macrophage,-0.248775747452397,-1.63526978640576,0.00144843154074945
INTERFERON GAMMA RESPONSE,Mature Luminal,-0.294954583337756,NA,> 0.05
INTERFERON GAMMA RESPONSE,Monocyte,-0.255807455570361,-1.50163421803006,0.0101067429634412
INTERFERON GAMMA RESPONSE,Myoepithelial,0.0620763564895532,NA,> 0.05
INTERFERON GAMMA RESPONSE,NK cells,-0.050648471343301,0,> 0.05
INTERFERON GAMMA RESPONSE,NKT cells,-0.605967827649117,0,> 0.05
INTERFERON GAMMA RESPONSE,Plasmablasts,-0.38791113314447,0,> 0.05
INTERFERON GAMMA RESPONSE,PVL Differentiated,-0.127134121375113,0,> 0.05
INTERFERON GAMMA RESPONSE,PVL Immature,-0.516388679059148,0,> 0.05
INTERFERON GAMMA RESPONSE,T cells CD4+,-0.10657653902011,0,> 0.05
INTERFERON GAMMA RESPONSE,T cells CD8+,-0.375214588007977,0,> 0.05
KRAS SIGNALING DN,B cells Memory,0.426584484434639,0,> 0.05
KRAS SIGNALING DN,B cells Naive,0.357295238218762,NA,> 0.05
KRAS SIGNALING DN,CAFs MSC iCAF-like,-0.0818867223586132,0,> 0.05
KRAS SIGNALING DN,CAFs myCAF-like,-0.143942294454116,0,> 0.05
KRAS SIGNALING DN,Cancer Basal SC,-0.12980715961245,0,> 0.05
KRAS SIGNALING DN,Cancer Cycling,0.449642337490731,0,> 0.05
KRAS SIGNALING DN,Cancer Her2 SC,0.352609158847142,0,> 0.05
KRAS SIGNALING DN,Cancer LumA SC,0.461972317118333,0,> 0.05
KRAS SIGNALING DN,Cancer LumB SC,0.478535296376383,0,> 0.05
KRAS SIGNALING DN,Cycling PVL,-0.1189044796264,0,> 0.05
KRAS SIGNALING DN,Cycling T-cells,0.243455345350676,0,0
KRAS SIGNALING DN,Cycling Myeloid,0.222344915527284,0,> 0.05
KRAS SIGNALING DN,DCs,0.488458754659303,0,> 0.05
KRAS SIGNALING DN,Endothelial ACKR1,0.105537959349653,0,> 0.05
KRAS SIGNALING DN,Endothelial CXCL12,-0.324637870436258,0,> 0.05
KRAS SIGNALING DN,Endothelial Lymphatic LYVE1,0.437351932929359,0,0
KRAS SIGNALING DN,Endothelial RGS5,0.407698573034898,0,> 0.05
KRAS SIGNALING DN,Luminal Progenitors,0.0586847290124583,NA,> 0.05
KRAS SIGNALING DN,Macrophage,0.68519995696389,0,> 0.05
KRAS SIGNALING DN,Mature Luminal,0.490276611832284,NA,> 0.05
KRAS SIGNALING DN,Monocyte,0.217624392858924,0,> 0.05
KRAS SIGNALING DN,Myoepithelial,0.157247491267439,NA,> 0.05
KRAS SIGNALING DN,NK cells,0.691256465525719,0,> 0.05
KRAS SIGNALING DN,NKT cells,0.604165606026572,0,> 0.05
KRAS SIGNALING DN,Plasmablasts,0.474825635655598,0,> 0.05
KRAS SIGNALING DN,PVL Differentiated,0.0357312364477988,0,> 0.05
KRAS SIGNALING DN,PVL Immature,0.41379150307277,0,> 0.05
KRAS SIGNALING DN,T cells CD4+,0.601100572699985,0,> 0.05
KRAS SIGNALING DN,T cells CD8+,0.640809630380264,0,> 0.05
KRAS SIGNALING UP,B cells Memory,0.109677189540284,0,> 0.05
KRAS SIGNALING UP,B cells Naive,0.369331480841169,NA,> 0.05
KRAS SIGNALING UP,CAFs MSC iCAF-like,0.0593056726357327,0,> 0.05
KRAS SIGNALING UP,CAFs myCAF-like,0.0317799959560606,0,> 0.05
KRAS SIGNALING UP,Cancer Basal SC,-0.0163282739092702,0,> 0.05
KRAS SIGNALING UP,Cancer Cycling,-0.274508350800646,0,> 0.05
KRAS SIGNALING UP,Cancer Her2 SC,-0.264808354366808,0,> 0.05
KRAS SIGNALING UP,Cancer LumA SC,-0.449859284348463,0,> 0.05
KRAS SIGNALING UP,Cancer LumB SC,-0.269484415153785,0,> 0.05
KRAS SIGNALING UP,Cycling PVL,0.393000496129013,0,> 0.05
KRAS SIGNALING UP,Cycling T-cells,0.259578258654229,0,0
KRAS SIGNALING UP,Cycling Myeloid,0.385939988882452,0,> 0.05
KRAS SIGNALING UP,DCs,0.459772898807347,0,> 0.05
KRAS SIGNALING UP,Endothelial ACKR1,-0.479012088928512,0,> 0.05
KRAS SIGNALING UP,Endothelial CXCL12,0.399860276652261,0,> 0.05
KRAS SIGNALING UP,Endothelial Lymphatic LYVE1,-0.395686719546544,0,0
KRAS SIGNALING UP,Endothelial RGS5,0.267399217725673,0,> 0.05
KRAS SIGNALING UP,Luminal Progenitors,0.363463327604131,NA,> 0.05
KRAS SIGNALING UP,Macrophage,0.206123645986737,0,> 0.05
KRAS SIGNALING UP,Mature Luminal,0.426455922571075,NA,> 0.05
KRAS SIGNALING UP,Monocyte,-0.0198076445717621,0,> 0.05
KRAS SIGNALING UP,Myoepithelial,0.1747522416729,NA,> 0.05
KRAS SIGNALING UP,NK cells,-0.276256056372928,0,> 0.05
KRAS SIGNALING UP,NKT cells,-0.0474750514871705,0,> 0.05
KRAS SIGNALING UP,Plasmablasts,0.265667021004649,0,> 0.05
KRAS SIGNALING UP,PVL Differentiated,0.180401474959857,0,> 0.05
KRAS SIGNALING UP,PVL Immature,-0.247279172227907,0,> 0.05
KRAS SIGNALING UP,T cells CD4+,0.162939802314007,0,> 0.05
KRAS SIGNALING UP,T cells CD8+,0.0387307603422403,0,> 0.05
MITOTIC SPINDLE,B cells Memory,-0.273112826894631,0,> 0.05
MITOTIC SPINDLE,B cells Naive,-0.364804904810651,NA,> 0.05
MITOTIC SPINDLE,CAFs MSC iCAF-like,-0.0526780283141644,0,> 0.05
MITOTIC SPINDLE,CAFs myCAF-like,0.318731118259988,0,> 0.05
MITOTIC SPINDLE,Cancer Basal SC,-0.107920833293459,0,> 0.05
MITOTIC SPINDLE,Cancer Cycling,0.196160945235204,0,> 0.05
MITOTIC SPINDLE,Cancer Her2 SC,0.21855571030123,0,> 0.05
MITOTIC SPINDLE,Cancer LumA SC,-0.237588720937805,0,> 0.05
MITOTIC SPINDLE,Cancer LumB SC,0.0868871408569383,0,> 0.05
MITOTIC SPINDLE,Cycling PVL,0.426151431125713,1.64925786075888,0.00536098959520674
MITOTIC SPINDLE,Cycling T-cells,0.230022502526014,0,0
MITOTIC SPINDLE,Cycling Myeloid,-0.244345423545668,0,> 0.05
MITOTIC SPINDLE,DCs,0.251559893368772,0,> 0.05
MITOTIC SPINDLE,Endothelial ACKR1,-0.00319417674302442,0,> 0.05
MITOTIC SPINDLE,Endothelial CXCL12,0.207970435074842,0,> 0.05
MITOTIC SPINDLE,Endothelial Lymphatic LYVE1,0.430090575968184,0,0
MITOTIC SPINDLE,Endothelial RGS5,-0.0416806061050829,0,> 0.05
MITOTIC SPINDLE,Luminal Progenitors,0.498962175247355,NA,> 0.05
MITOTIC SPINDLE,Macrophage,0.027354522049524,0,> 0.05
MITOTIC SPINDLE,Mature Luminal,0.337133528643575,NA,> 0.05
MITOTIC SPINDLE,Monocyte,-0.0903006674122237,0,> 0.05
MITOTIC SPINDLE,Myoepithelial,0.413744831101042,NA,> 0.05
MITOTIC SPINDLE,NK cells,0.332607458258972,0,> 0.05
MITOTIC SPINDLE,NKT cells,0.123802350863631,0,> 0.05
MITOTIC SPINDLE,Plasmablasts,0.475026052434696,0,> 0.05
MITOTIC SPINDLE,PVL Differentiated,0.334024818003466,0,> 0.05
MITOTIC SPINDLE,PVL Immature,0.449968644927919,0,> 0.05
MITOTIC SPINDLE,T cells CD4+,0.0348881195841854,0,> 0.05
MITOTIC SPINDLE,T cells CD8+,0.088971690811639,0,> 0.05
MTORC1 SIGNALING,B cells Memory,0.457763212408185,0,> 0.05
MTORC1 SIGNALING,B cells Naive,0.261197503371783,NA,> 0.05
MTORC1 SIGNALING,CAFs MSC iCAF-like,-0.219995999255465,0,> 0.05
MTORC1 SIGNALING,CAFs myCAF-like,0.0366591744913528,0,> 0.05
MTORC1 SIGNALING,Cancer Basal SC,-0.0608935883706981,0,> 0.05
MTORC1 SIGNALING,Cancer Cycling,0.0878573932590577,0,> 0.05
MTORC1 SIGNALING,Cancer Her2 SC,0.180165141288232,0,> 0.05
MTORC1 SIGNALING,Cancer LumA SC,0.397650067973373,0,> 0.05
MTORC1 SIGNALING,Cancer LumB SC,0.0803054513024598,0,> 0.05
MTORC1 SIGNALING,Cycling PVL,-0.0804110828497636,0,> 0.05
MTORC1 SIGNALING,Cycling T-cells,0.00737557567352832,0,0
MTORC1 SIGNALING,Cycling Myeloid,0.293673560961803,0,> 0.05
MTORC1 SIGNALING,DCs,0.433780750802296,0,> 0.05
MTORC1 SIGNALING,Endothelial ACKR1,-0.330640312715921,0,> 0.05
MTORC1 SIGNALING,Endothelial CXCL12,-0.283259061705444,0,> 0.05
MTORC1 SIGNALING,Endothelial Lymphatic LYVE1,-0.240987810951348,0,0
MTORC1 SIGNALING,Endothelial RGS5,-0.555084774695798,0,> 0.05
MTORC1 SIGNALING,Luminal Progenitors,-0.216760357746758,NA,> 0.05
MTORC1 SIGNALING,Macrophage,0.0774354509440677,0,> 0.05
MTORC1 SIGNALING,Mature Luminal,-0.279686917628533,NA,> 0.05
MTORC1 SIGNALING,Monocyte,-0.0989242129189449,0,> 0.05
MTORC1 SIGNALING,Myoepithelial,0.139450222929379,NA,> 0.05
MTORC1 SIGNALING,NK cells,-0.0259314859570687,0,> 0.05
MTORC1 SIGNALING,NKT cells,-0.0202139764597773,0,> 0.05
MTORC1 SIGNALING,Plasmablasts,-0.436978302126321,0,> 0.05
MTORC1 SIGNALING,PVL Differentiated,0.00463762481486359,0,> 0.05
MTORC1 SIGNALING,PVL Immature,-0.498220822916936,0,> 0.05
MTORC1 SIGNALING,T cells CD4+,0.0220189350654464,0,> 0.05
MTORC1 SIGNALING,T cells CD8+,-0.0405238047234273,0,> 0.05
MYC TARGETS V1,B cells Memory,0.230884173471164,-2.07880080925502,5.04452653608738e-09
MYC TARGETS V1,B cells Naive,0.161478862439898,NA,> 0.05
MYC TARGETS V1,CAFs MSC iCAF-like,-0.446877800108313,-2.04238644198267,2.85670165088935e-07
MYC TARGETS V1,CAFs myCAF-like,-0.40338482547279,-1.9532401241338,3.08673034973227e-06
MYC TARGETS V1,Cancer Basal SC,-0.138251489768439,-2.18592797046696,9.31498874604834e-11
MYC TARGETS V1,Cancer Cycling,-0.0636144889367391,-2.48145912786892,7.10719673757854e-13
MYC TARGETS V1,Cancer Her2 SC,-0.0520364790726901,0,> 0.05
MYC TARGETS V1,Cancer LumA SC,0.224040823461755,-1.9520165215531,3.15730869092954e-05
MYC TARGETS V1,Cancer LumB SC,-0.0576836843918764,-1.76485657959394,0.0016487547922921
MYC TARGETS V1,Cycling PVL,-0.0939288803010985,0,> 0.05
MYC TARGETS V1,Cycling T-cells,-0.0740784734581599,0,0
MYC TARGETS V1,Cycling Myeloid,0.135883048881808,0,> 0.05
MYC TARGETS V1,DCs,-0.37060933501993,0,> 0.05
MYC TARGETS V1,Endothelial ACKR1,-0.489482830437501,-2.01406278714741,3.96959662160309e-09
MYC TARGETS V1,Endothelial CXCL12,-0.449998190124382,-2.03582661514557,1.20940176423032e-08
MYC TARGETS V1,Endothelial Lymphatic LYVE1,-0.326232337342514,0,0
MYC TARGETS V1,Endothelial RGS5,-0.520041825590852,-1.91905061888507,1.21388314416771e-07
MYC TARGETS V1,Luminal Progenitors,-0.230688694977221,NA,> 0.05
MYC TARGETS V1,Macrophage,-0.478386668991586,-1.94351293347848,4.22546002811451e-06
MYC TARGETS V1,Mature Luminal,-0.283765022124077,NA,> 0.05
MYC TARGETS V1,Monocyte,-0.374405456190641,-2.01473044393578,2.36960903073142e-06
MYC TARGETS V1,Myoepithelial,-0.19535859310874,NA,> 0.05
MYC TARGETS V1,NK cells,-0.363019970459398,-2.03846201526003,1.99142111782131e-06
MYC TARGETS V1,NKT cells,-0.428706772140584,0,> 0.05
MYC TARGETS V1,Plasmablasts,-0.543899678443432,-2.2489379837174,3.18743653452159e-10
MYC TARGETS V1,PVL Differentiated,-0.405162065770575,-1.76317337858195,0.00016613758543072
MYC TARGETS V1,PVL Immature,-0.620091428885098,-2.20506346022947,7.98118421840089e-11
MYC TARGETS V1,T cells CD4+,-0.416246013306792,-2.27604147117285,7.19321014546331e-13
MYC TARGETS V1,T cells CD8+,-0.37318490051959,-2.10082329819675,2.64309575244038e-10
MYC TARGETS V2,B cells Memory,0.656869755255432,0,> 0.05
MYC TARGETS V2,B cells Naive,0.247875152232589,NA,> 0.05
MYC TARGETS V2,CAFs MSC iCAF-like,-0.11117344794534,0,> 0.05
MYC TARGETS V2,CAFs myCAF-like,-0.340785541546642,0,> 0.05
MYC TARGETS V2,Cancer Basal SC,-0.130824983071223,0,> 0.05
MYC TARGETS V2,Cancer Cycling,-0.343653913293069,0,> 0.05
MYC TARGETS V2,Cancer Her2 SC,-0.227445756570956,0,> 0.05
MYC TARGETS V2,Cancer LumA SC,-0.248896726666629,0,> 0.05
MYC TARGETS V2,Cancer LumB SC,-0.487306665989323,0,> 0.05
MYC TARGETS V2,Cycling PVL,-0.625808103756121,0,> 0.05
MYC TARGETS V2,Cycling T-cells,0.0744222858297875,0,0
MYC TARGETS V2,Cycling Myeloid,0.23712876190952,0,> 0.05
MYC TARGETS V2,DCs,0.23246337826967,0,> 0.05
MYC TARGETS V2,Endothelial ACKR1,-0.360853571853904,0,> 0.05
MYC TARGETS V2,Endothelial CXCL12,-0.202338429920462,0,> 0.05
MYC TARGETS V2,Endothelial Lymphatic LYVE1,-0.269104355145934,0,0
MYC TARGETS V2,Endothelial RGS5,-0.229023903148028,0,> 0.05
MYC TARGETS V2,Luminal Progenitors,-0.408072723346205,NA,> 0.05
MYC TARGETS V2,Macrophage,0.368844162846665,0,> 0.05
MYC TARGETS V2,Mature Luminal,-0.136003376572067,NA,> 0.05
MYC TARGETS V2,Monocyte,0.154214329809028,0,> 0.05
MYC TARGETS V2,Myoepithelial,0.42637577248159,NA,> 0.05
MYC TARGETS V2,NK cells,0.179952140632763,0,> 0.05
MYC TARGETS V2,NKT cells,0.417348000939635,0,> 0.05
MYC TARGETS V2,Plasmablasts,0.490424469668041,0,> 0.05
MYC TARGETS V2,PVL Differentiated,0.155475501566018,0,> 0.05
MYC TARGETS V2,PVL Immature,-0.270778268150293,0,> 0.05
MYC TARGETS V2,T cells CD4+,0.149939968844724,0,> 0.05
MYC TARGETS V2,T cells CD8+,0.246351815693868,0,> 0.05
MYOGENESIS,B cells Memory,-0.0839095511095344,0,> 0.05
MYOGENESIS,B cells Naive,-0.106881133159779,NA,> 0.05
MYOGENESIS,CAFs MSC iCAF-like,0.0303568924290668,0,> 0.05
MYOGENESIS,CAFs myCAF-like,0.350588334339642,0,> 0.05
MYOGENESIS,Cancer Basal SC,0.3505985268583,0,> 0.05
MYOGENESIS,Cancer Cycling,0.243414288793802,0,> 0.05
MYOGENESIS,Cancer Her2 SC,0.0971259158895178,0,> 0.05
MYOGENESIS,Cancer LumA SC,0.0395113655902162,0,> 0.05
MYOGENESIS,Cancer LumB SC,0.203701542812974,0,> 0.05
MYOGENESIS,Cycling PVL,0.376435556990911,0,> 0.05
MYOGENESIS,Cycling T-cells,-0.00717840474053203,0,0
MYOGENESIS,Cycling Myeloid,0.35210619368019,0,> 0.05
MYOGENESIS,DCs,0.57455329536151,0,> 0.05
MYOGENESIS,Endothelial ACKR1,0.144617724967544,0,> 0.05
MYOGENESIS,Endothelial CXCL12,0.585191331074844,0,> 0.05
MYOGENESIS,Endothelial Lymphatic LYVE1,0.346163307737104,0,0
MYOGENESIS,Endothelial RGS5,-0.0516161554023791,0,> 0.05
MYOGENESIS,Luminal Progenitors,0.425865077982202,NA,> 0.05
MYOGENESIS,Macrophage,0.515426792493636,0,> 0.05
MYOGENESIS,Mature Luminal,0.212692830788775,NA,> 0.05
MYOGENESIS,Monocyte,0.533610987667514,0,> 0.05
MYOGENESIS,Myoepithelial,0.107035190059343,NA,> 0.05
MYOGENESIS,NK cells,0.222388922530081,0,> 0.05
MYOGENESIS,NKT cells,0.68690905378586,0,> 0.05
MYOGENESIS,Plasmablasts,0.442475803588391,0,> 0.05
MYOGENESIS,PVL Differentiated,0.121592113635915,0,> 0.05
MYOGENESIS,PVL Immature,0.221054090513657,0,> 0.05
MYOGENESIS,T cells CD4+,0.283473005031492,0,> 0.05
MYOGENESIS,T cells CD8+,0.337833647006487,0,> 0.05
NOTCH SIGNALING,B cells Memory,-0.437735020436439,0,> 0.05
NOTCH SIGNALING,B cells Naive,-0.119186585134033,NA,> 0.05
NOTCH SIGNALING,CAFs MSC iCAF-like,-0.357206840891836,0,> 0.05
NOTCH SIGNALING,CAFs myCAF-like,0.0259309024512891,0,> 0.05
NOTCH SIGNALING,Cancer Basal SC,-0.0431709214640719,0,> 0.05
NOTCH SIGNALING,Cancer Cycling,-0.512660104313363,0,> 0.05
NOTCH SIGNALING,Cancer Her2 SC,-0.472609640605028,0,> 0.05
NOTCH SIGNALING,Cancer LumA SC,-0.361615709053972,0,> 0.05
NOTCH SIGNALING,Cancer LumB SC,-0.30678094876725,0,> 0.05
NOTCH SIGNALING,Cycling PVL,0.137620221336078,0,> 0.05
NOTCH SIGNALING,Cycling T-cells,-0.342714373771027,0,0
NOTCH SIGNALING,Cycling Myeloid,-0.57242445653836,0,> 0.05
NOTCH SIGNALING,DCs,-0.312084084385581,0,> 0.05
NOTCH SIGNALING,Endothelial ACKR1,-0.0691532634625026,0,> 0.05
NOTCH SIGNALING,Endothelial CXCL12,-0.376721633540945,0,> 0.05
NOTCH SIGNALING,Endothelial Lymphatic LYVE1,0.118112687273016,0,0
NOTCH SIGNALING,Endothelial RGS5,-0.49771081089705,0,> 0.05
NOTCH SIGNALING,Luminal Progenitors,-0.0296955598837086,NA,> 0.05
NOTCH SIGNALING,Macrophage,-0.123572134833495,0,> 0.05
NOTCH SIGNALING,Mature Luminal,-0.417591538835927,NA,> 0.05
NOTCH SIGNALING,Monocyte,0.0340227399955347,0,> 0.05
NOTCH SIGNALING,Myoepithelial,-0.321918995970534,NA,> 0.05
NOTCH SIGNALING,NK cells,0.0229080433993718,0,> 0.05
NOTCH SIGNALING,NKT cells,-0.0304361257083844,0,> 0.05
NOTCH SIGNALING,Plasmablasts,0.115967861012047,0,> 0.05
NOTCH SIGNALING,PVL Differentiated,0.12619795583332,0,> 0.05
NOTCH SIGNALING,PVL Immature,0.361448154412452,0,> 0.05
NOTCH SIGNALING,T cells CD4+,-0.329738194088576,0,> 0.05
NOTCH SIGNALING,T cells CD8+,-0.131554796496068,0,> 0.05
OXIDATIVE PHOSPHORYLATION,B cells Memory,-0.51203050254829,-2.31122421670673,1.2512436590867e-12
OXIDATIVE PHOSPHORYLATION,B cells Naive,0.0254835262910453,NA,> 0.05
OXIDATIVE PHOSPHORYLATION,CAFs MSC iCAF-like,-0.163151628386417,0,> 0.05
OXIDATIVE PHOSPHORYLATION,CAFs myCAF-like,-0.47703165172054,-1.88408914074848,6.05070002921896e-05
OXIDATIVE PHOSPHORYLATION,Cancer Basal SC,-0.228387052377126,-2.20369566012455,9.31498874604834e-11
OXIDATIVE PHOSPHORYLATION,Cancer Cycling,-0.0262686488755933,-1.99516148481544,1.85153243675014e-06
OXIDATIVE PHOSPHORYLATION,Cancer Her2 SC,0.0196612648325204,0,> 0.05
OXIDATIVE PHOSPHORYLATION,Cancer LumA SC,0.291749561877955,0,> 0.05
OXIDATIVE PHOSPHORYLATION,Cancer LumB SC,0.00702144385171387,-1.65971019851353,0.0100504974776168
OXIDATIVE PHOSPHORYLATION,Cycling PVL,-0.0958598523144643,0,> 0.05
OXIDATIVE PHOSPHORYLATION,Cycling T-cells,-0.39555773228733,0,0
OXIDATIVE PHOSPHORYLATION,Cycling Myeloid,0.21346204789497,0,> 0.05
OXIDATIVE PHOSPHORYLATION,DCs,-0.448513333086071,0,> 0.05
OXIDATIVE PHOSPHORYLATION,Endothelial ACKR1,-0.629506361432581,-2.14078978002587,5.11382393539905e-11
OXIDATIVE PHOSPHORYLATION,Endothelial CXCL12,-0.568290481622425,-2.02743671332115,6.15809371577301e-08
OXIDATIVE PHOSPHORYLATION,Endothelial Lymphatic LYVE1,-0.718906961859973,0,0
OXIDATIVE PHOSPHORYLATION,Endothelial RGS5,-0.841335791915212,-1.97619499294807,4.87561291789244e-08
OXIDATIVE PHOSPHORYLATION,Luminal Progenitors,-0.292244349345423,NA,> 0.05
OXIDATIVE PHOSPHORYLATION,Macrophage,-0.42962532560122,-2.48726912198484,2.70657726712263e-12
OXIDATIVE PHOSPHORYLATION,Mature Luminal,-0.34672731428699,NA,> 0.05
OXIDATIVE PHOSPHORYLATION,Monocyte,-0.516212543216022,-1.87401983060322,3.81187685002867e-05
OXIDATIVE PHOSPHORYLATION,Myoepithelial,-0.25815404925471,NA,> 0.05
OXIDATIVE PHOSPHORYLATION,NK cells,-0.475306209886238,-2.11886359527547,3.06914567942427e-07
OXIDATIVE PHOSPHORYLATION,NKT cells,-0.571150275273415,0,> 0.05
OXIDATIVE PHOSPHORYLATION,Plasmablasts,-0.533381525942645,-2.10354691473408,1.54777369949269e-07
OXIDATIVE PHOSPHORYLATION,PVL Differentiated,-0.714906706620602,-2.03165198118196,4.68922818722556e-07
OXIDATIVE PHOSPHORYLATION,PVL Immature,-0.677903945798907,-2.2498387959707,3.52555493567691e-11
OXIDATIVE PHOSPHORYLATION,T cells CD4+,-0.596711577099518,-2.41544864053721,3.3030282114817e-15
OXIDATIVE PHOSPHORYLATION,T cells CD8+,-0.634111437546121,-2.15792485454247,1.62175559067745e-11
P53 PATHWAY,B cells Memory,0.518890537514244,0,> 0.05
P53 PATHWAY,B cells Naive,0.294134196974631,NA,> 0.05
P53 PATHWAY,CAFs MSC iCAF-like,0.225371191848993,0,> 0.05
P53 PATHWAY,CAFs myCAF-like,0.531313206347049,0,> 0.05
P53 PATHWAY,Cancer Basal SC,0.0499876331868349,0,> 0.05
P53 PATHWAY,Cancer Cycling,0.362801842382608,0,> 0.05
P53 PATHWAY,Cancer Her2 SC,0.0706450016779314,0,> 0.05
P53 PATHWAY,Cancer LumA SC,0.501215928920408,0,> 0.05
P53 PATHWAY,Cancer LumB SC,0.340456319866514,0,> 0.05
P53 PATHWAY,Cycling PVL,0.17281009877922,0,> 0.05
P53 PATHWAY,Cycling T-cells,0.468794888598476,0,0
P53 PATHWAY,Cycling Myeloid,0.663008240970564,0,> 0.05
P53 PATHWAY,DCs,0.72865585012908,0,> 0.05
P53 PATHWAY,Endothelial ACKR1,0.176593743531989,0,> 0.05
P53 PATHWAY,Endothelial CXCL12,-0.157501757884372,0,> 0.05
P53 PATHWAY,Endothelial Lymphatic LYVE1,0.166978977065341,0,0
P53 PATHWAY,Endothelial RGS5,0.252832015231849,0,> 0.05
P53 PATHWAY,Luminal Progenitors,-0.072414947925239,NA,> 0.05
P53 PATHWAY,Macrophage,0.724879512488161,0,> 0.05
P53 PATHWAY,Mature Luminal,-0.226080078706127,NA,> 0.05
P53 PATHWAY,Monocyte,0.454427773515109,0,> 0.05
P53 PATHWAY,Myoepithelial,-0.178650072393564,NA,> 0.05
P53 PATHWAY,NK cells,0.226548320653395,0,> 0.05
P53 PATHWAY,NKT cells,0.266208951958144,0,> 0.05
P53 PATHWAY,Plasmablasts,-0.213535128720384,0,> 0.05
P53 PATHWAY,PVL Differentiated,0.0470682136356503,0,> 0.05
P53 PATHWAY,PVL Immature,-0.211042007358246,0,> 0.05
P53 PATHWAY,T cells CD4+,0.322011122074575,0,> 0.05
P53 PATHWAY,T cells CD8+,0.275523392421695,0,> 0.05
PANCREAS BETA CELLS,B cells Memory,-0.544611200044554,0,> 0.05
PANCREAS BETA CELLS,B cells Naive,-0.389622129976312,NA,> 0.05
PANCREAS BETA CELLS,CAFs MSC iCAF-like,-0.477775981808078,0,> 0.05
PANCREAS BETA CELLS,CAFs myCAF-like,-0.12244059515279,0,> 0.05
PANCREAS BETA CELLS,Cancer Basal SC,0.476170123319974,0,> 0.05
PANCREAS BETA CELLS,Cancer Cycling,0.489491109816911,0,> 0.05
PANCREAS BETA CELLS,Cancer Her2 SC,0.503416728576418,0,> 0.05
PANCREAS BETA CELLS,Cancer LumA SC,0.534506105636729,0,> 0.05
PANCREAS BETA CELLS,Cancer LumB SC,0.635333592043441,0,> 0.05
PANCREAS BETA CELLS,Cycling PVL,-0.320169041837165,0,> 0.05
PANCREAS BETA CELLS,Cycling T-cells,0.371174522187198,0,0
PANCREAS BETA CELLS,Cycling Myeloid,-0.161746756081932,0,> 0.05
PANCREAS BETA CELLS,DCs,-0.512605158057169,0,> 0.05
PANCREAS BETA CELLS,Endothelial ACKR1,-0.412489813471498,0,> 0.05
PANCREAS BETA CELLS,Endothelial CXCL12,-0.124519716036817,0,> 0.05
PANCREAS BETA CELLS,Endothelial Lymphatic LYVE1,-0.100040799978076,0,0
PANCREAS BETA CELLS,Endothelial RGS5,-0.294139203940997,0,> 0.05
PANCREAS BETA CELLS,Luminal Progenitors,0.244027463791742,NA,> 0.05
PANCREAS BETA CELLS,Macrophage,-0.238363316826201,0,> 0.05
PANCREAS BETA CELLS,Mature Luminal,-0.438342844986927,NA,> 0.05
PANCREAS BETA CELLS,Monocyte,-0.165726420895903,0,> 0.05
PANCREAS BETA CELLS,Myoepithelial,-0.142056701551646,NA,> 0.05
PANCREAS BETA CELLS,NK cells,-0.348090389678213,0,> 0.05
PANCREAS BETA CELLS,NKT cells,-0.705438959512929,0,> 0.05
PANCREAS BETA CELLS,Plasmablasts,-0.64811040069837,0,> 0.05
PANCREAS BETA CELLS,PVL Differentiated,-0.522356668082774,0,> 0.05
PANCREAS BETA CELLS,PVL Immature,-0.567284614843757,0,> 0.05
PANCREAS BETA CELLS,T cells CD4+,-0.527738253759363,0,> 0.05
PANCREAS BETA CELLS,T cells CD8+,-0.586379100053216,0,> 0.05
PEROXISOME,B cells Memory,-0.696551686279388,0,> 0.05
PEROXISOME,B cells Naive,0.372825365564865,NA,> 0.05
PEROXISOME,CAFs MSC iCAF-like,-0.42727677703713,0,> 0.05
PEROXISOME,CAFs myCAF-like,-0.391190196190147,0,> 0.05
PEROXISOME,Cancer Basal SC,0.216338953815222,0,> 0.05
PEROXISOME,Cancer Cycling,0.170051256876795,0,> 0.05
PEROXISOME,Cancer Her2 SC,0.38696323745362,0,> 0.05
PEROXISOME,Cancer LumA SC,0.484753532589524,0,> 0.05
PEROXISOME,Cancer LumB SC,0.259965330158366,0,> 0.05
PEROXISOME,Cycling PVL,-0.651214592263943,0,> 0.05
PEROXISOME,Cycling T-cells,-0.648366816618759,0,0
PEROXISOME,Cycling Myeloid,0.565519451309343,0,> 0.05
PEROXISOME,DCs,-0.289110844047833,0,> 0.05
PEROXISOME,Endothelial ACKR1,-0.677065261723166,0,> 0.05
PEROXISOME,Endothelial CXCL12,-0.814155242256065,0,> 0.05
PEROXISOME,Endothelial Lymphatic LYVE1,-0.0880322756593249,0,0
PEROXISOME,Endothelial RGS5,-0.713597475996172,0,> 0.05
PEROXISOME,Luminal Progenitors,-0.434273501456222,NA,> 0.05
PEROXISOME,Macrophage,-0.420602020198926,0,> 0.05
PEROXISOME,Mature Luminal,-0.471769260043605,NA,> 0.05
PEROXISOME,Monocyte,-0.368797310466958,0,> 0.05
PEROXISOME,Myoepithelial,0.0770479874195032,NA,> 0.05
PEROXISOME,NK cells,-0.264561300629595,0,> 0.05
PEROXISOME,NKT cells,-0.521640049543704,0,> 0.05
PEROXISOME,Plasmablasts,-0.340577249687773,0,> 0.05
PEROXISOME,PVL Differentiated,-0.764659684402235,0,> 0.05
PEROXISOME,PVL Immature,-0.889377791224457,0,> 0.05
PEROXISOME,T cells CD4+,-0.628063398919136,-1.75125946862933,0.00191893650188239
PEROXISOME,T cells CD8+,-0.583074781137414,0,> 0.05
PI3K AKT MTOR SIGNALING,B cells Memory,0.225941099569481,0,> 0.05
PI3K AKT MTOR SIGNALING,B cells Naive,0.383311448924051,NA,> 0.05
PI3K AKT MTOR SIGNALING,CAFs MSC iCAF-like,-0.0480330218161858,0,> 0.05
PI3K AKT MTOR SIGNALING,CAFs myCAF-like,-0.157660732842823,0,> 0.05
PI3K AKT MTOR SIGNALING,Cancer Basal SC,-0.341794970967199,0,> 0.05
PI3K AKT MTOR SIGNALING,Cancer Cycling,-0.0960350783858249,0,> 0.05
PI3K AKT MTOR SIGNALING,Cancer Her2 SC,0.494948856706441,0,> 0.05
PI3K AKT MTOR SIGNALING,Cancer LumA SC,0.310169218848619,0,> 0.05
PI3K AKT MTOR SIGNALING,Cancer LumB SC,-0.191787114218763,0,> 0.05
PI3K AKT MTOR SIGNALING,Cycling PVL,0.0697130444632947,0,> 0.05
PI3K AKT MTOR SIGNALING,Cycling T-cells,-0.0695833715642334,0,0
PI3K AKT MTOR SIGNALING,Cycling Myeloid,0.189837569970533,0,> 0.05
PI3K AKT MTOR SIGNALING,DCs,0.171847332355632,0,> 0.05
PI3K AKT MTOR SIGNALING,Endothelial ACKR1,-0.0113346905619278,0,> 0.05
PI3K AKT MTOR SIGNALING,Endothelial CXCL12,-0.113434673291323,0,> 0.05
PI3K AKT MTOR SIGNALING,Endothelial Lymphatic LYVE1,0.0864365763327452,0,0
PI3K AKT MTOR SIGNALING,Endothelial RGS5,0.129464346523282,0,> 0.05
PI3K AKT MTOR SIGNALING,Luminal Progenitors,0.242054918581016,NA,> 0.05
PI3K AKT MTOR SIGNALING,Macrophage,0.0550781644850416,0,> 0.05
PI3K AKT MTOR SIGNALING,Mature Luminal,-0.489204523559283,NA,> 0.05
PI3K AKT MTOR SIGNALING,Monocyte,-0.316988406255414,0,> 0.05
PI3K AKT MTOR SIGNALING,Myoepithelial,0.285614382695042,NA,> 0.05
PI3K AKT MTOR SIGNALING,NK cells,-0.469598566135703,0,> 0.05
PI3K AKT MTOR SIGNALING,NKT cells,-0.558735621150002,0,> 0.05
PI3K AKT MTOR SIGNALING,Plasmablasts,-0.375528242047478,0,> 0.05
PI3K AKT MTOR SIGNALING,PVL Differentiated,-0.017635676651617,0,> 0.05
PI3K AKT MTOR SIGNALING,PVL Immature,-0.222172139912733,0,> 0.05
PI3K AKT MTOR SIGNALING,T cells CD4+,-0.189086155760929,0,> 0.05
PI3K AKT MTOR SIGNALING,T cells CD8+,-0.460963976303203,0,> 0.05
PROTEIN SECRETION,B cells Memory,-0.344237226960351,0,> 0.05
PROTEIN SECRETION,B cells Naive,0.302870781279168,NA,> 0.05
PROTEIN SECRETION,CAFs MSC iCAF-like,-0.417857315616052,0,> 0.05
PROTEIN SECRETION,CAFs myCAF-like,-0.139485330925377,0,> 0.05
PROTEIN SECRETION,Cancer Basal SC,-0.373460117489992,0,> 0.05
PROTEIN SECRETION,Cancer Cycling,-0.0180755192899993,0,> 0.05
PROTEIN SECRETION,Cancer Her2 SC,-0.122146067451706,0,> 0.05
PROTEIN SECRETION,Cancer LumA SC,0.0453227339085764,0,> 0.05
PROTEIN SECRETION,Cancer LumB SC,0.0486593716884174,0,> 0.05
PROTEIN SECRETION,Cycling PVL,0.30002122632972,0,> 0.05
PROTEIN SECRETION,Cycling T-cells,0.0989809322922602,0,0
PROTEIN SECRETION,Cycling Myeloid,-0.233024220249926,0,> 0.05
PROTEIN SECRETION,DCs,-0.276017206013525,0,> 0.05
PROTEIN SECRETION,Endothelial ACKR1,-0.801043598024017,-1.71452750159603,0.00209704682485143
PROTEIN SECRETION,Endothelial CXCL12,-0.620458015112781,0,> 0.05
PROTEIN SECRETION,Endothelial Lymphatic LYVE1,-0.658900897990908,0,0
PROTEIN SECRETION,Endothelial RGS5,-0.61653594319404,0,> 0.05
PROTEIN SECRETION,Luminal Progenitors,-0.611004310914492,NA,> 0.05
PROTEIN SECRETION,Macrophage,-0.284630230120113,0,> 0.05
PROTEIN SECRETION,Mature Luminal,-0.514769502058954,NA,> 0.05
PROTEIN SECRETION,Monocyte,-0.240713656279772,0,> 0.05
PROTEIN SECRETION,Myoepithelial,-0.173569620165679,NA,> 0.05
PROTEIN SECRETION,NK cells,-0.297409452285563,0,> 0.05
PROTEIN SECRETION,NKT cells,-0.430581638259006,0,> 0.05
PROTEIN SECRETION,Plasmablasts,-0.533969578568128,-1.56230670535788,0.0268588679071135
PROTEIN SECRETION,PVL Differentiated,0.00111427316892682,0,> 0.05
PROTEIN SECRETION,PVL Immature,-0.634682879366466,0,> 0.05
PROTEIN SECRETION,T cells CD4+,-0.0972648462111167,0,> 0.05
PROTEIN SECRETION,T cells CD8+,-0.154347563502917,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,B cells Memory,0.469399766079338,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,B cells Naive,0.418393747479335,NA,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,CAFs MSC iCAF-like,-0.25294940911877,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,CAFs myCAF-like,-0.427005581104425,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,Cancer Basal SC,-0.0684550804901509,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,Cancer Cycling,-0.0133177679013905,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,Cancer Her2 SC,0.073670907477211,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,Cancer LumA SC,0.317258330853959,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,Cancer LumB SC,0.205173238243032,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,Cycling PVL,0.284933212749504,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,Cycling T-cells,-0.492055322003263,0,0
REACTIVE OXYGEN SPECIES PATHWAY,Cycling Myeloid,0.457906275144521,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,DCs,-0.0756436453515734,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,Endothelial ACKR1,-0.663714269946842,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,Endothelial CXCL12,-0.598735638632761,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,Endothelial Lymphatic LYVE1,-0.354740472178594,0,0
REACTIVE OXYGEN SPECIES PATHWAY,Endothelial RGS5,-0.213612869589313,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,Luminal Progenitors,-0.320842779546281,NA,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,Macrophage,0.127810389630705,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,Mature Luminal,-0.274071439918893,NA,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,Monocyte,0.185901706864353,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,Myoepithelial,-0.0800149544523965,NA,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,NK cells,0.400005492187053,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,NKT cells,-0.218318565948748,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,Plasmablasts,-0.490088610570544,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,PVL Differentiated,-0.486522786019055,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,PVL Immature,-0.771101514598336,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,T cells CD4+,0.246963368795266,0,> 0.05
REACTIVE OXYGEN SPECIES PATHWAY,T cells CD8+,0.0500021240054902,0,> 0.05
SPERMATOGENESIS,B cells Memory,-0.237721233264923,0,> 0.05
SPERMATOGENESIS,B cells Naive,-0.341609266353979,NA,> 0.05
SPERMATOGENESIS,CAFs MSC iCAF-like,0.367406079677726,0,> 0.05
SPERMATOGENESIS,CAFs myCAF-like,-0.445287030793809,0,> 0.05
SPERMATOGENESIS,Cancer Basal SC,-0.273564866577571,0,> 0.05
SPERMATOGENESIS,Cancer Cycling,-0.212207013565523,0,> 0.05
SPERMATOGENESIS,Cancer Her2 SC,-0.349690515341588,0,> 0.05
SPERMATOGENESIS,Cancer LumA SC,-0.439752203239809,0,> 0.05
SPERMATOGENESIS,Cancer LumB SC,-0.606656600290776,0,> 0.05
SPERMATOGENESIS,Cycling PVL,0.177553273412572,0,> 0.05
SPERMATOGENESIS,Cycling T-cells,0.530063707145575,0,0
SPERMATOGENESIS,Cycling Myeloid,0.407650558966893,0,> 0.05
SPERMATOGENESIS,DCs,0.272038732268174,0,> 0.05
SPERMATOGENESIS,Endothelial ACKR1,0.347134392041075,0,> 0.05
SPERMATOGENESIS,Endothelial CXCL12,0.611036971410824,0,> 0.05
SPERMATOGENESIS,Endothelial Lymphatic LYVE1,0.0707969607105069,0,0
SPERMATOGENESIS,Endothelial RGS5,0.454162192615818,0,> 0.05
SPERMATOGENESIS,Luminal Progenitors,0.489770563653474,NA,> 0.05
SPERMATOGENESIS,Macrophage,0.403213717104781,0,> 0.05
SPERMATOGENESIS,Mature Luminal,-0.133115250847921,NA,> 0.05
SPERMATOGENESIS,Monocyte,0.0607784590624505,0,> 0.05
SPERMATOGENESIS,Myoepithelial,-0.184054616846237,NA,> 0.05
SPERMATOGENESIS,NK cells,0.505949272628526,0,> 0.05
SPERMATOGENESIS,NKT cells,0.116223386801834,0,> 0.05
SPERMATOGENESIS,Plasmablasts,0.418541113079153,0,> 0.05
SPERMATOGENESIS,PVL Differentiated,0.0703678098915941,0,> 0.05
SPERMATOGENESIS,PVL Immature,-0.230876661506324,0,> 0.05
SPERMATOGENESIS,T cells CD4+,0.01258574336627,0,> 0.05
SPERMATOGENESIS,T cells CD8+,0.374147967461458,0,> 0.05
TGF BETA SIGNALING,B cells Memory,0.581355508700689,0,> 0.05
TGF BETA SIGNALING,B cells Naive,-0.4333088472439,NA,> 0.05
TGF BETA SIGNALING,CAFs MSC iCAF-like,0.426984469447773,0,> 0.05
TGF BETA SIGNALING,CAFs myCAF-like,0.675937260752564,0,> 0.05
TGF BETA SIGNALING,Cancer Basal SC,0.0708963280273517,0,> 0.05
TGF BETA SIGNALING,Cancer Cycling,0.0407591411022221,0,> 0.05
TGF BETA SIGNALING,Cancer Her2 SC,0.339052565602254,0,> 0.05
TGF BETA SIGNALING,Cancer LumA SC,0.148637350474325,0,> 0.05
TGF BETA SIGNALING,Cancer LumB SC,0.0322469058491962,0,> 0.05
TGF BETA SIGNALING,Cycling PVL,0.678835473133064,2.45132089523996,8.64202641200501e-06
TGF BETA SIGNALING,Cycling T-cells,0.419906475467971,0,0
TGF BETA SIGNALING,Cycling Myeloid,0.646431354919745,0,> 0.05
TGF BETA SIGNALING,DCs,0.570632194013275,0,> 0.05
TGF BETA SIGNALING,Endothelial ACKR1,0.394217136005318,0,> 0.05
TGF BETA SIGNALING,Endothelial CXCL12,0.375477537727159,1.89551396440437,0.00511201980307677
TGF BETA SIGNALING,Endothelial Lymphatic LYVE1,0.240226155379121,0,0
TGF BETA SIGNALING,Endothelial RGS5,0.229223511798447,0,> 0.05
TGF BETA SIGNALING,Luminal Progenitors,0.518089343097636,NA,> 0.05
TGF BETA SIGNALING,Macrophage,0.580797769473788,0,> 0.05
TGF BETA SIGNALING,Mature Luminal,0.420645635521612,NA,> 0.05
TGF BETA SIGNALING,Monocyte,0.352129382311693,0,> 0.05
TGF BETA SIGNALING,Myoepithelial,0.337250316677062,NA,> 0.05
TGF BETA SIGNALING,NK cells,0.116485393718147,0,> 0.05
TGF BETA SIGNALING,NKT cells,0.155524674210481,0,> 0.05
TGF BETA SIGNALING,Plasmablasts,0.388768537195276,0,> 0.05
TGF BETA SIGNALING,PVL Differentiated,0.466505010009758,0,> 0.05
TGF BETA SIGNALING,PVL Immature,0.383951586639228,0,> 0.05
TGF BETA SIGNALING,T cells CD4+,0.557727489274749,0,> 0.05
TGF BETA SIGNALING,T cells CD8+,0.295064937613461,0,> 0.05
TNFA SIGNALING VIA NFKB,B cells Memory,0.648488691091497,0,> 0.05
TNFA SIGNALING VIA NFKB,B cells Naive,0.365200916782209,NA,> 0.05
TNFA SIGNALING VIA NFKB,CAFs MSC iCAF-like,0.146618930400261,0,> 0.05
TNFA SIGNALING VIA NFKB,CAFs myCAF-like,0.57521308697395,1.88439101276579,6.27530995488125e-05
TNFA SIGNALING VIA NFKB,Cancer Basal SC,-0.21107229258079,0,> 0.05
TNFA SIGNALING VIA NFKB,Cancer Cycling,0.0704247802957545,0,> 0.05
TNFA SIGNALING VIA NFKB,Cancer Her2 SC,-0.24238288849459,0,> 0.05
TNFA SIGNALING VIA NFKB,Cancer LumA SC,0.340912463603798,0,> 0.05
TNFA SIGNALING VIA NFKB,Cancer LumB SC,-0.0920161818880436,0,> 0.05
TNFA SIGNALING VIA NFKB,Cycling PVL,0.58887659301102,2.54148932937468,2.41058177486866e-10
TNFA SIGNALING VIA NFKB,Cycling T-cells,0.432825184475858,0,0
TNFA SIGNALING VIA NFKB,Cycling Myeloid,0.36402818691409,0,> 0.05
TNFA SIGNALING VIA NFKB,DCs,0.654605786429909,2.7354730124735,1.00739981538698e-20
TNFA SIGNALING VIA NFKB,Endothelial ACKR1,0.145980567630335,0,> 0.05
TNFA SIGNALING VIA NFKB,Endothelial CXCL12,-0.0762499682679172,0,> 0.05
TNFA SIGNALING VIA NFKB,Endothelial Lymphatic LYVE1,0.256808111848276,0,0
TNFA SIGNALING VIA NFKB,Endothelial RGS5,0.297536016231083,1.57662647734858,0.00324843726864875
TNFA SIGNALING VIA NFKB,Luminal Progenitors,-0.060326713010344,NA,> 0.05
TNFA SIGNALING VIA NFKB,Macrophage,0.566137355485052,2.06622733770974,8.5273715994259e-07
TNFA SIGNALING VIA NFKB,Mature Luminal,-0.276048307551769,NA,> 0.05
TNFA SIGNALING VIA NFKB,Monocyte,0.390051304491251,2.01816054169781,2.36960903073142e-06
TNFA SIGNALING VIA NFKB,Myoepithelial,-0.00556716235511235,NA,> 0.05
TNFA SIGNALING VIA NFKB,NK cells,0.186595105630515,0,> 0.05
TNFA SIGNALING VIA NFKB,NKT cells,0.438636451195061,2.17466433891783,8.35414098977008e-08
TNFA SIGNALING VIA NFKB,Plasmablasts,-0.285197146501538,0,> 0.05
TNFA SIGNALING VIA NFKB,PVL Differentiated,0.210396264938865,1.80419273645047,7.90271653895931e-05
TNFA SIGNALING VIA NFKB,PVL Immature,-0.167387664776135,0,> 0.05
TNFA SIGNALING VIA NFKB,T cells CD4+,0.406899968384738,1.92684889761204,1.72165269975689e-06
TNFA SIGNALING VIA NFKB,T cells CD8+,0.385090201937194,1.61013425279551,0.00327577641309672
UNFOLDED PROTEIN RESPONSE,B cells Memory,0.38994915646998,0,> 0.05
UNFOLDED PROTEIN RESPONSE,B cells Naive,0.191484875031464,NA,> 0.05
UNFOLDED PROTEIN RESPONSE,CAFs MSC iCAF-like,-0.434845873487398,0,> 0.05
UNFOLDED PROTEIN RESPONSE,CAFs myCAF-like,0.156696914221032,0,> 0.05
UNFOLDED PROTEIN RESPONSE,Cancer Basal SC,0.0348516784415979,0,> 0.05
UNFOLDED PROTEIN RESPONSE,Cancer Cycling,-0.151671050765925,0,> 0.05
UNFOLDED PROTEIN RESPONSE,Cancer Her2 SC,0.010569855812166,0,> 0.05
UNFOLDED PROTEIN RESPONSE,Cancer LumA SC,0.261414089730698,0,> 0.05
UNFOLDED PROTEIN RESPONSE,Cancer LumB SC,-0.243100442506094,0,> 0.05
UNFOLDED PROTEIN RESPONSE,Cycling PVL,-0.0236547815610313,0,> 0.05
UNFOLDED PROTEIN RESPONSE,Cycling T-cells,0.273455337954511,0,0
UNFOLDED PROTEIN RESPONSE,Cycling Myeloid,0.367446031696697,0,> 0.05
UNFOLDED PROTEIN RESPONSE,DCs,0.230278284198787,0,> 0.05
UNFOLDED PROTEIN RESPONSE,Endothelial ACKR1,-0.494911468408621,0,> 0.05
UNFOLDED PROTEIN RESPONSE,Endothelial CXCL12,-0.38370743479796,0,> 0.05
UNFOLDED PROTEIN RESPONSE,Endothelial Lymphatic LYVE1,-0.310414764310425,0,0
UNFOLDED PROTEIN RESPONSE,Endothelial RGS5,-0.633300141472391,0,> 0.05
UNFOLDED PROTEIN RESPONSE,Luminal Progenitors,-0.252801056287624,NA,> 0.05
UNFOLDED PROTEIN RESPONSE,Macrophage,0.348130172155341,0,> 0.05
UNFOLDED PROTEIN RESPONSE,Mature Luminal,-0.373959454596303,NA,> 0.05
UNFOLDED PROTEIN RESPONSE,Monocyte,0.350170274951855,0,> 0.05
UNFOLDED PROTEIN RESPONSE,Myoepithelial,0.127248570486171,NA,> 0.05
UNFOLDED PROTEIN RESPONSE,NK cells,-0.21152821106252,0,> 0.05
UNFOLDED PROTEIN RESPONSE,NKT cells,-0.10955140646448,0,> 0.05
UNFOLDED PROTEIN RESPONSE,Plasmablasts,-0.482380674620225,0,> 0.05
UNFOLDED PROTEIN RESPONSE,PVL Differentiated,-0.437397184603205,0,> 0.05
UNFOLDED PROTEIN RESPONSE,PVL Immature,-0.61556773766229,0,> 0.05
UNFOLDED PROTEIN RESPONSE,T cells CD4+,-0.245614956715057,0,> 0.05
UNFOLDED PROTEIN RESPONSE,T cells CD8+,-0.10925622568795,0,> 0.05
UV RESPONSE DN,B cells Memory,-0.048509003308904,0,> 0.05
UV RESPONSE DN,B cells Naive,-0.323011111706859,NA,> 0.05
UV RESPONSE DN,CAFs MSC iCAF-like,0.271629328567805,0,> 0.05
UV RESPONSE DN,CAFs myCAF-like,0.537422561745314,1.92077417873201,0.000118703178738906
UV RESPONSE DN,Cancer Basal SC,0.225699644194949,0,> 0.05
UV RESPONSE DN,Cancer Cycling,0.222524279206688,0,> 0.05
UV RESPONSE DN,Cancer Her2 SC,0.0965994824957054,0,> 0.05
UV RESPONSE DN,Cancer LumA SC,-0.0327297722788669,0,> 0.05
UV RESPONSE DN,Cancer LumB SC,-0.0294971532051443,0,> 0.05
UV RESPONSE DN,Cycling PVL,0.587709376634318,2.00538390969825,0.000186586596396974
UV RESPONSE DN,Cycling T-cells,0.203242035964673,0,0
UV RESPONSE DN,Cycling Myeloid,0.187310918532387,0,> 0.05
UV RESPONSE DN,DCs,0.408957756287796,0,> 0.05
UV RESPONSE DN,Endothelial ACKR1,0.250366465469527,0,> 0.05
UV RESPONSE DN,Endothelial CXCL12,0.0689075492622174,0,> 0.05
UV RESPONSE DN,Endothelial Lymphatic LYVE1,-0.0955883751801885,0,0
UV RESPONSE DN,Endothelial RGS5,-0.029336797536379,0,> 0.05
UV RESPONSE DN,Luminal Progenitors,0.302065335987247,NA,> 0.05
UV RESPONSE DN,Macrophage,0.469622984852043,0,> 0.05
UV RESPONSE DN,Mature Luminal,0.466572126015675,NA,> 0.05
UV RESPONSE DN,Monocyte,0.484424399609113,0,> 0.05
UV RESPONSE DN,Myoepithelial,-0.00883901746081481,NA,> 0.05
UV RESPONSE DN,NK cells,0.5675814922137,0,> 0.05
UV RESPONSE DN,NKT cells,0.572371932539048,0,> 0.05
UV RESPONSE DN,Plasmablasts,0.447184433070028,0,> 0.05
UV RESPONSE DN,PVL Differentiated,0.280812571602086,0,> 0.05
UV RESPONSE DN,PVL Immature,0.236012004352163,0,> 0.05
UV RESPONSE DN,T cells CD4+,0.592508119237102,0,> 0.05
UV RESPONSE DN,T cells CD8+,0.581447376539613,0,> 0.05
UV RESPONSE UP,B cells Memory,0.620382672182224,0,> 0.05
UV RESPONSE UP,B cells Naive,0.22313697163348,NA,> 0.05
UV RESPONSE UP,CAFs MSC iCAF-like,-0.0379202806011139,0,> 0.05
UV RESPONSE UP,CAFs myCAF-like,0.226888928495911,0,> 0.05
UV RESPONSE UP,Cancer Basal SC,-0.341767221620347,0,> 0.05
UV RESPONSE UP,Cancer Cycling,0.141856224639953,0,> 0.05
UV RESPONSE UP,Cancer Her2 SC,-0.0745954315835524,0,> 0.05
UV RESPONSE UP,Cancer LumA SC,0.399032834082681,0,> 0.05
UV RESPONSE UP,Cancer LumB SC,0.102603639070128,0,> 0.05
UV RESPONSE UP,Cycling PVL,0.424930975089779,0,> 0.05
UV RESPONSE UP,Cycling T-cells,0.495155762152123,0,0
UV RESPONSE UP,Cycling Myeloid,0.681614923630214,0,> 0.05
UV RESPONSE UP,DCs,0.610817213156902,0,> 0.05
UV RESPONSE UP,Endothelial ACKR1,-0.154072796711255,0,> 0.05
UV RESPONSE UP,Endothelial CXCL12,-0.300318639879585,0,> 0.05
UV RESPONSE UP,Endothelial Lymphatic LYVE1,-0.0808456249298706,0,0
UV RESPONSE UP,Endothelial RGS5,0.0158647959193419,0,> 0.05
UV RESPONSE UP,Luminal Progenitors,-0.199269703655343,NA,> 0.05
UV RESPONSE UP,Macrophage,0.641373845820704,0,> 0.05
UV RESPONSE UP,Mature Luminal,-0.18644463573322,NA,> 0.05
UV RESPONSE UP,Monocyte,0.361002447811963,0,> 0.05
UV RESPONSE UP,Myoepithelial,0.027609721323959,NA,> 0.05
UV RESPONSE UP,NK cells,0.108996607908757,0,> 0.05
UV RESPONSE UP,NKT cells,0.290345212935446,0,> 0.05
UV RESPONSE UP,Plasmablasts,-0.28638279171729,0,> 0.05
UV RESPONSE UP,PVL Differentiated,0.100108369745221,0,> 0.05
UV RESPONSE UP,PVL Immature,-0.230240595219009,0,> 0.05
UV RESPONSE UP,T cells CD4+,0.413357124561022,0,> 0.05
UV RESPONSE UP,T cells CD8+,0.348349227638994,0,> 0.05
WNT BETA CATENIN SIGNALING,B cells Memory,-0.0780472183631249,0,> 0.05
WNT BETA CATENIN SIGNALING,B cells Naive,-0.25145200144367,NA,> 0.05
WNT BETA CATENIN SIGNALING,CAFs MSC iCAF-like,-0.572456457893605,0,> 0.05
WNT BETA CATENIN SIGNALING,CAFs myCAF-like,0.292276802974893,0,> 0.05
WNT BETA CATENIN SIGNALING,Cancer Basal SC,0.0872742282645265,0,> 0.05
WNT BETA CATENIN SIGNALING,Cancer Cycling,-0.246086263267428,0,> 0.05
WNT BETA CATENIN SIGNALING,Cancer Her2 SC,-0.186075402024069,0,> 0.05
WNT BETA CATENIN SIGNALING,Cancer LumA SC,-0.328933535084766,0,> 0.05
WNT BETA CATENIN SIGNALING,Cancer LumB SC,-0.420135370697646,0,> 0.05
WNT BETA CATENIN SIGNALING,Cycling PVL,0.354464918845689,0,> 0.05
WNT BETA CATENIN SIGNALING,Cycling T-cells,0.259983919252173,0,0
WNT BETA CATENIN SIGNALING,Cycling Myeloid,0.0960677323668205,0,> 0.05
WNT BETA CATENIN SIGNALING,DCs,-0.316307112928245,0,> 0.05
WNT BETA CATENIN SIGNALING,Endothelial ACKR1,0.08598331598009,0,> 0.05
WNT BETA CATENIN SIGNALING,Endothelial CXCL12,0.068884551969501,0,> 0.05
WNT BETA CATENIN SIGNALING,Endothelial Lymphatic LYVE1,0.232350956549996,0,0
WNT BETA CATENIN SIGNALING,Endothelial RGS5,-0.3847910288782,0,> 0.05
WNT BETA CATENIN SIGNALING,Luminal Progenitors,-0.137043907944469,NA,> 0.05
WNT BETA CATENIN SIGNALING,Macrophage,-0.192754959342007,0,> 0.05
WNT BETA CATENIN SIGNALING,Mature Luminal,0.154376057767592,NA,> 0.05
WNT BETA CATENIN SIGNALING,Monocyte,-0.461008666561542,0,> 0.05
WNT BETA CATENIN SIGNALING,Myoepithelial,-0.429977442252816,NA,> 0.05
WNT BETA CATENIN SIGNALING,NK cells,-0.507404582298444,0,> 0.05
WNT BETA CATENIN SIGNALING,NKT cells,-0.0938188131735047,0,> 0.05
WNT BETA CATENIN SIGNALING,Plasmablasts,0.172791460403579,0,> 0.05
WNT BETA CATENIN SIGNALING,PVL Differentiated,0.297412277109144,0,> 0.05
WNT BETA CATENIN SIGNALING,PVL Immature,-0.379855600829198,0,> 0.05
WNT BETA CATENIN SIGNALING,T cells CD4+,-0.175477188824795,0,> 0.05
WNT BETA CATENIN SIGNALING,T cells CD8+,-0.00459956265863636,0,> 0.05
XENOBIOTIC METABOLISM,B cells Memory,-0.265781683622148,0,> 0.05
XENOBIOTIC METABOLISM,B cells Naive,-0.0285618504381333,NA,> 0.05
XENOBIOTIC METABOLISM,CAFs MSC iCAF-like,-0.147228127093034,0,> 0.05
XENOBIOTIC METABOLISM,CAFs myCAF-like,-0.435419494566781,0,> 0.05
XENOBIOTIC METABOLISM,Cancer Basal SC,-0.373406213726574,0,> 0.05
XENOBIOTIC METABOLISM,Cancer Cycling,0.140810776824331,0,> 0.05
XENOBIOTIC METABOLISM,Cancer Her2 SC,-0.0122654993476046,0,> 0.05
XENOBIOTIC METABOLISM,Cancer LumA SC,0.27109461498615,0,> 0.05
XENOBIOTIC METABOLISM,Cancer LumB SC,0.221453667422821,0,> 0.05
XENOBIOTIC METABOLISM,Cycling PVL,0.298912960271242,0,> 0.05
XENOBIOTIC METABOLISM,Cycling T-cells,-0.132117064511346,0,0
XENOBIOTIC METABOLISM,Cycling Myeloid,0.169083998426111,0,> 0.05
XENOBIOTIC METABOLISM,DCs,-0.319802222256125,0,> 0.05
XENOBIOTIC METABOLISM,Endothelial ACKR1,-0.33874266850968,0,> 0.05
XENOBIOTIC METABOLISM,Endothelial CXCL12,-0.316024269015874,0,> 0.05
XENOBIOTIC METABOLISM,Endothelial Lymphatic LYVE1,-0.185405821368677,0,0
XENOBIOTIC METABOLISM,Endothelial RGS5,-0.253785399425688,0,> 0.05
XENOBIOTIC METABOLISM,Luminal Progenitors,-0.302449383988067,NA,> 0.05
XENOBIOTIC METABOLISM,Macrophage,-0.126187782732337,0,> 0.05
XENOBIOTIC METABOLISM,Mature Luminal,-0.328906891916559,NA,> 0.05
XENOBIOTIC METABOLISM,Monocyte,0.0886553258790611,0,> 0.05
XENOBIOTIC METABOLISM,Myoepithelial,0.0109570416285004,NA,> 0.05
XENOBIOTIC METABOLISM,NK cells,0.532377300426982,0,> 0.05
XENOBIOTIC METABOLISM,NKT cells,-0.00039893951597408,0,> 0.05
XENOBIOTIC METABOLISM,Plasmablasts,-0.137616665257632,-1.88331752421569,6.67611525197796e-05
XENOBIOTIC METABOLISM,PVL Differentiated,-0.616931647486768,0,> 0.05
XENOBIOTIC METABOLISM,PVL Immature,-0.792524919592724,0,> 0.05
XENOBIOTIC METABOLISM,T cells CD4+,0.0429682482718998,0,> 0.05
XENOBIOTIC METABOLISM,T cells CD8+,0.229877715093019,0,> 0.05
